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In neurons, normal distribution and selective removal of mitochondria are essential for 










removal. However, it is not clear how Parkin plays a role in mitochondrial turnover in 
vivo, and whether the mature neurons possess a compartmentalized Parkin-dependent 
mitochondrial life cycle. Using the live Drosophila nervous system, here, I investigate 
the involvement of Parkin in mitochondrial dynamics; organelle distribution, morphology 
and removal. Parkin deficient animals displayed less number of axonal mitochondria 
without disturbing organelle motility behaviors, morphology and metabolic state. Instead, 
loss of Parkin produced tubular and reticular mitochondria specifically in motor neuronal 
cell body. In addition, unlike in immortalized cells in vitro, Parkin-dependent mitophagy 
was rarely found in our mature neurons. Thus, my results indicate that mitochondrial 
morphology is restrictively modulated in the cell body in Parkin-dependent manner, and 
this further proposes an idea that the organelle supply from the cell body is important for 








CHAPTER 1. INTRODUCTION 
 
 
1.1 Mitochondria in Neurons 
 
Neurons are specialized cells that process and transmit information through 
electrochemical signals. They are electrically excitable and morphologically asymmetric, 
and highly differentiated to demand large amounts of ATP for the maintenance of ionic 
gradients across the cellular membranes and for release of neurotransmitter at synapses. 
Among the neuronal components, mitochondria are unique and central organelles for 
ATP production, intracellular Ca2+ homeostasis and generation of reactive oxygen 
species (ROS). Since these various cellular functions of mitochondria are all critical in 
membrane excitability and synaptic plasticity, neuronal activity and survival are 
significantly dependent upon mitochondrial function. As a consequence, proper 
maintenance of functional mitochondria and/or removal of damaged mitochondria should 
be understood to better comprehend the physiological behavior of neurons (Fiskum et al., 
1999; Nicholls and Budd, 2000). 
 In neurons, mitochondria are dynamic organelles that display an intricate life 
cycle. They undergo constant movements (Stowers et al., 2002; Guo et al., 2005; Glater 
et al., 2006; Pilling et al., 2006; Reis et al., 2009), continuous shape changes (Okamoto 
and Shaw, 2005; Chan, 2006; Song et al., 2009) with complex biogenesis and 
degradation (Davis and Clayton, 1996; Amiri and Hollenbeck, 2008; Maday et al., 2012; 
Ashrafi et al., 2014). Though less is known about the molecular underpinnings of the 
mitochondrial life cycle in neurons in vivo, there is some recent evidence that disruptions 
of mitochondrial dynamics are associated with several major neurodegenerative diseases 
   	
   	  (Palacino et al., 2004; Dodson and Guo, 2007; 
Gautier et al., 2008; Mortiboys et al., 2008; Wood-Kaczmar et al., 2008). Therefore,
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exploring mitochondrial dynamics and life cycle is essential to understanding the 
complex physiological behavior of neurons, as well as the underlying pathogenesis of 
neurological diseases.  
 
 
1.1.1 Mitochondrial axonal transport 
Neurons are morphologically asymmetric and polarized cells that exhibit a dramatic 
example of cellular compartmentalization. Since neurons are compartmentalized into 
three distinct regions - the cell body, a long axon and synaptic terminal - their distinct 
subcellular regions are physically and functionally organized. For this reason, proper 
distribution and normal localization of their organelles among the somatodendritic, 
axonal and synaptic compartments (Hollenbeck and Saxton, 2005; Hirokawa et al., 2010; 
Saxton and Hollenbeck, 2012) are important for polarized neuronal functions. 
Mitochondria are no exception to this strategic positioning of organelles within neurons, 
since they serve major metabolic demands at various locations such as active growth 
cones, distal synapses and nodes of Ranvier (Hollenbeck and Saxton, 2005; Sheng and 
Cai, 2012).  
 In neurons, axonal transport is the major generator of organelle distribution and 
localization. Through axonal transport, components within neurons can move 
anterogradely from the cell body to the synaptic terminal and also return back 
retrogradely toward the cell body from the distal synaptic regions. Among the neuronal 
components, mitochondria are one of the categories of organelle that display saltatory 
and bidirectional movements, especially in the axons and dendrites (Morris and 
Hollenbeck, 1993; Hollenbeck, 1996). Commonly, bidirectional movements of 
mitochondria are thought to be associated with the place where the organelles are needed 
and/or degraded in neurons. Several studies provide evidence of mitochondrial transport 
organized to meet local demands. One example is the behavior of mitochondria in a 
myelinated nerve. There, mitochondrial movements are generally reduced in nodal 
axoplasm compared with internodal and juxtaparanodal axoplasm. Axonal electrical 
activity, however, increases the size of mitochondrial stationary clusters and decreases 
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mitochondrial motility in nodal axoplasm. Conversely, decreased axonal electrical 
activity increases the motile fraction of mitochondria in the node of Ranvier (Kiryu-Seo 
et al., 2010; Ohno et al., 2011). Since clusters of sodium channels and sodium/potassium 
ATPases are found at the nodes, the regions near the node of Ranvier generally have a 
high energy demand. Thus, these modulations of mitochondrial recruitment described 
above probably represent a response to axonal electrical activity and/or elevated 
axoplasmic calcium ion levels.  
 It is unsurprising that many neurodegenerative diseases are reported to involve 
disruptions of mitochondrial axonal transport. Impaired mitochondrial transport has been 
observed in hippocampal neurons     	
  (Rui et al., 2006; Vossel et al., 
2010), and mitochondrial accumulations were found in degenerated axons in patients 
  	      (Stokin et al., 2005). In addition, neurons from patients 
with amyotrophic lateral sclerosis (ALS) (Sasaki and Iwata, 1996) and from mice that 
express ALS-related superoxide dismutase 1 (SOD1) mutantions displayed impaired 
mitochondrial axonal transport (De Vos et al., 2007; Shi et al., 2010). Furthermore, recent 
studies indicate that the impaired mitochondrial axonal transport is critically involved in 
  
           
    
role as an integrator for intracellular vesicular trafficking, including mitochondria (Chang 
et al., 2006; Colin et al., 2008; Caviston and Holzbaur, 2009). Though it has not been 
demonstrated the direct evidences for defective mitochondrial 	 	    !
disease (PD), Parkin, E3 ubiquitin ligase that is associated with familial PD, is proposed 
to be linked with mitochondrial transport (Wang et al., 2011; Liu et al., 2012). Thus, 
further investigation is required to elucidate the role of mitochondrial movements in 
neurodegenerative diseases, such as PD.  
So far, little is known about how the movements of mitochondria are closely 
modulated in response to regional neuronal requirements and how the motility patterns of 
mitochondria are altered in models of neuronal diseases. However, here, I provide an 
overview of the trafficking machineries that contribute to the complex nature of 
mitochondrial transport, and introduce five proposed models that describe how the 
movements of mitochondria might be regulated in neurons. 
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1.1.1.1 Trafficking machinery, motor proteins 
It is interesting that axons contain a linear array of polarized microtubules (MTs): the 
plus ends of axonal MTs are arranged towards the distal tips, whereas the minus ends are 
directed toward the cell body. This uniform arrangement of MTs underlies 
distinguishable and organized bidirectional, anterograde and retrograde, movements of 
neuronal cargos. Like most organelles in animal cells, the axonal transport of 
mitochondria is mainly MT-based. There are two major motor proteins for MT-based 
mitochondrial movements, kinesin-1 and dynein (Figure 1.1). Conventional kinesin 
motors, kinesin-1 (also called kinesin heavy chain or Kif5), are responsible for the 
anterograde transport towards the synaptic terminal, while dynein motors are responsible 
for the retrograde transport towards the cell body. Since the absence of kinesin-1 and 
dynein dramatically disrupts the transport of mitochondria in Drosophila motor axons 
(Pilling et al., 2006), recent study clearly suggests the key role of these two major MT 
associated motor proteins in mitochondrial axonal transport.  
Interestingly, the anterograde trafficking motor, kinesin, forms a protein complex 
with the mitochondrial proteins Miro and milton (Stowers et al., 2002; Guo et al., 2005; 
Glater et al., 2006; Reis et al., 2009). Milton is a motor adaptor protein that is associated 
with kinesin and linked indirectly to mitochondria through an interaction with Miro, a 
mitochondrial rho GTPase which is present in the mitochondrial outer membrane. 
Mutation of miro or milton genes in Drosophila caused impaired mitochondrial 
anterograde transport. This suggests that Miro, milton and kinesin constitute a transport 
system specific for the mitochondrial anterograde movement. So far, it is not clear 
whether Miro/milton complex is also involved in dynein-mediated retrograde 
mitochondrial transport. However, a recent study provides direct evidence for a 
biochemical interaction that TRAK1 (the mammalian homolog of milton) binds to both 
kinesin-1 and dynein (van Spronsen et al., 2013).  
 In addition to MT-based motor proteins, kinesin and dynein, syntaphilin is a well-
known axonal MT associated protein that is thought to anchor mitochondria (Kang et al., 
2008). Syntaphilin is located in the outer membrane of stationary axonal mitochondria 
and contains a MT-binding domain, so it is thought to anchor mitochondria through direct 
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interactions with MTs. Interestingly, deletion of the mouse syntaphilin resulted in an 
increased proportion of mobile axonal mitochondria (Kang et al., 2008). However, 
syntaphilin is only found in mammals. Since other model animals, such as Drosophila, 
also show a similar pattern of a stationary pool of mitochondria in axons, further studies 
are needed to fully understand mitochondrial anchoring mechanisms to MTs.  
 Generally, in axons, long-range mitochondrial transport is driven by MT-based 
kinesin and dynein motors, while short-range mitochondrial transport is thought to be 
mediated by actin-based motors (Morris and Hollenbeck, 1995). Myosin is a major motor 
protein that mediated mitochondrial transports with actin microfilaments. Though it 
remains unknown how myosins bind to mitochondria, a study in Drosophila neurons 
suggests that RNAi knockdown of myosin proteins increased run lengths and net 
movements of mitochondria (Pathak et al., 2010). Additionally, nerve growth factor can 
regulate mitochondrial transports by interactions between mitochondria and actin 
cytoskeleton (Chada and Hollenbeck, 2004).  
 
1.1.1.2 Regulation of mitochondrial movement 
If mitochondria move so as to supply local neuronal energy demands and to meet their 
own physiological purposes, the axonal transport of mitochondria ought to be closely 
modulated between mobile and stationary pools. In axons, mitochondria display dynamic 
patterns of behavior including consistent anterograde and retrograde movement with 
occasional reversals, stops and starts (Hollenbeck and Saxton, 2005; Saxton and 
Hollenbeck, 2012). So far, however, it is unknown how these movements of 
mitochondria, especially changes in direction and/or changes between movement and 
arrest, are regulated in axons. Here, I summarize five models that have been proposed for 
explaining the regulation of mitochondrial transport, how mitochondria are arrested.  
 Since syntaphilin (SNPH), which contains MT-binding domain, was observed on 
stationary axonal mitochondria (Kang et al., 2008), this protein has been proposed to be a 
static anchor for mitochondria on MT tracks (Figure 1.2, B). The time-lapse observations 
that visualized GFP-SNPH-labeled mitochondria showed that they remained stationary, 
while GFP-SNPH-negative mitochondria migrated along the axonal process. This 
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provided evidence of an anchoring role of syntaphilin in mitochondrial transport (Kang et 
al., 2008). Thus, syntaphilin is a candidate docking protein, and could play a role in how 
mobile axonal mitochondria are recruited to the stationary pool and arrested in local 
axonal sites.  
 Another proposed model for mitochondrial arrest is the involvement of actin 
microfilament associated protein, myosin (Figure 1.2, C). It is interesting that deletion of 
myosin V actually increased mitochondrial velocity in both directions, whereas RNAi 
knockdown of myosin VI specifically increased retrograde transport of mitochondria 
(Pathak et al., 2010). This is also consistent with the result that disruption of F-actin 
causes faster and more persistent mitochondrial axonal transport in cultured neurons 
(Morris and Hollenbeck, 1995). Though the manipulations of myosin proteins seem to 
regulate moving mitochondria selectively, this recent study suggests that myosins may 
arrest moving mitochondria by docking them to the actin cytoskeleton. By analogy with 
organelle transport in pigment cells (Rogers and Gelfand, 1998; Nascimento et al., 2003), 
it is possible that myosins compete with MT-based motor proteins, such as kinesins, and 
inhibit the moving mitochondria on MT tracks.  
 As described above, the Miro/milton complex is proposed to function as an 
adaptor between mitochondria and motor protein kinesin. Since the amino-terminal motor 
domain of kinesin binds to the MT tracks, the cutting off from the one of structural 
linkages within this motor protein complex will cause mitochondrial arrest. In this regard, 
it is notable that Miro contains two EF hands with Ca2+ binding motifs that can rearrange 
this motor protein complex. One suggested model of this complex modification is that the 
EF hands of Miro binds with increased cytosolic Ca2+ and release the motors completely 
from mitochondria (Macaskill et al., 2009). As a consequence, this conformational 
change would dissociate mitochondria from the MT tracks (Figure 1.2, D). Alternatively, 
another proposed model in this complex modification is that the motor domain of kinesin 
directly binds to Miro upon increased cytosolic Ca2+ (Wang and Schwarz, 2009). This 
rearrangement of motor protein complex causes motor protein release from the MT tracks 
and consequently arrest mitochondria (Figure 1.2, E). These proposed models, however, 
are not only contradictory, but fail to explain why the manipulations of Miro by increased 
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Ca2+ disrupt not only kinesin dependent anterograde movement, but also dynein 
dependent retrograde movement of mitochondria.  
 Recently, an additional model has been proposed to explain mitochondrial arrest 
by the modulation of the Miro/milton/kinesin motor protein complex. In this mechanism 
(Figure 1.2, F), two PD related proteins, PINK1 and Parkin, are involved. Interestingly, 
PINK1, as a mitochondrial membrane kinase, phosphorylates Miro, which activates the 
proteasomal degradation of Miro by the ubiquitin ligase activity of Parkin. As a result, 
PINK1/Parkin dissociates the linker protein, Miro, from the milton/kinesin motor protein 
complex, which in turn detaches mitochondria from the MT track (Wang et al., 2011). 
Like the other proposed models of this complex modification, the suggested mechanism 
fails to clarify why the manipulations of PINK1 and Parkin disrupt mitochondrial 
transport in both directions, and whether PINK1/Parkin regulates mitochondrial transport 
broadly in other cell or tissue types. However, this proposed model is intriguing and 




1.1.2 Mitochondrial fission and fusion 
In addition to axonal transport, mitochondria display continuous shape changes 
controlled by fission and fusion. Like mitochondrial transport, mitochondrial fission and 
fusion dynamics also can contribute to proper distribution of mitochondria within 
neurons. Indeed, mitochondrial fission may sequester, and mitochondrial fusion may 
dilute, the damaged components in mitochondrial networks to help maintain the proper 
function and distribution of organelles.  
Many of neurological diseases are associated with the disruptions in 
mitochondrial fission-fusion balance. It is reported that mutations in mitochondrial fusion 
protein cause Charcot-Maire-Tooth type 2A, a peripheral neuropathy characterized by 
sensory neuronal loss and muscle defects (Zuchner et al., 2004). In addition, an 
imbalance of mitochondrial fission-fusion was observed upon overexpression of APP, 
amyloid precursor protein associated with AD, in neuronal cells (Wang et al., 2008). 
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Furthermore, studies from Drosophila have suggested that two PD related genes, PINK1 
and Parkin, are also involved in regulation of mitochondrial morphology (Poole et al., 
2008). Thus, maintaining mitochondrial morphological balance between fission and 
fusion seems to be required for preserving normal mitochondrial functions and for 
protecting neurodegenerative diseases, such as PD.  
 Although many recent studies indicate the significance of mitochondrial 
morphology in neurodegenerative diseases, contradictory findings have been reported in 
these studies (Chen and Chan, 2009): normal ultrastructure of mitochondria was found in 
the striatum of PINK1 deletion mice (Gautier et al., 2008), while enlarged and swollen 
mitochondria were found in the flight muscle of PINK1/Parkin mutant flies (Poole et al., 
2008). Thus, further work is required to fully understand the role of mitochondrial 
fission-fusion dynamics in neurological diseases. Since mitochondria undergo a 
continuous cycle of fission and fusion in a regulated manner, here I summarize major 
proteins that regulate fission or fusion, respectively (Figure 1.3). 
 
1.1.2.1 Mitochondrial fission 
In mammalian cells, mitochondrial fission is regulated by two key proteins, Drp1 
(Smirnova et al., 2001) and Fis1 (James et al., 2003). Drp1, dynamin-related protein 1, is 
predominantly located in the cytosol but is recruited to mitochondrial surface for 
organelle division by mitochondrial outer membrane protein, Fis1. Recent studies showed 
that inhibition of Drp1 activity causes elongated mitochondria (Pitts et al., 1999), while 
overexpression of Drp1 results in mitochondrial fragmentation (Arnoult et al., 2005). It 
was also reported that the depletion of Fis1 causes elongated mitochondria, while the 
overexpression of Fis1 leads to mitochondrial fragmentation (Yoon et al., 2003). Indeed, 
the full mitochondrial fission process mediated by Drp1 and Fis1 contains three proposed 
steps. First, constriction of the mitochondrial membrane occurs initially without Drp1 
recruitment. Though the localization of Drp1 on mitochondrial surface is proposed to be 
independent of the initial constriction of the organelle, secondly, Fis1 recruits Drp1 to the 
scission site to further constrict the mitochondrial membrane. Finally, once mitochondrial 
scission is completed, Drp1 is disassembled from the daughter mitochondria (Chan, 2006) 
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(Figure 1.3, A). In this regard, a recent report that proposes the contribution of 
endoplasmic reticulum (ER) in mitochondrial division is worth noting. Since ER tubules 
constrict mitochondria before the Drp1 recruitment (Friedman et al., 2011), it is possible 
that the first step of mitochondrial division, the initial constriction of mitochondrial 
membrane, can be mediated by interactions with other organelles, such as ER.  
 
1.1.2.2 Mitochondrial fusion 
The detailed molecular mechanisms of mitochondrial fusion remain unclear, but studies 
from mammalian cells suggest that the fusion event is mediated by two major proteins: 
Mitofusins (Mfn1 and Mfn2) and optic atrophy protein 1 (Opa1). Mfn1 and Mfn2 are 
dynamin-related GTPases that are located in the outer membrane of mitochondria, while 
another dynamin-related GTPase, Opa1, resides in the inner membrane and/or 
intermembrane space of mitochondria (Okamoto and Shaw, 2005; Chan, 2006; Song et 
al., 2009). Recent studies indicate that mitochondria lacking either mitofusins or Opa1 
cannot undergo fusion, therefore resulting in a shortened and fragmented state (Chan, 
2006). Like mitochondrial fission, the fusion event is also known to require three 
consecutive steps: adjacent mitochondrial docking, mitochondrial outer membrane fusion 
and mitochondrial inner membrane fusion (Figure 1.3, B). Mitofusins are thought to play 
an important role in adjacent mitochondrial docking and further in the mitochondrial 
outer membrane fusion. Once those mitochondria are tethered by the outer membrane 
fusion, Opa1 is proposed to play a role in mitochondrial inner membrane fusion and 
further remodeling of cristae structure in newly fused mitochondria (Frezza et al., 2006).  
 
 
1.1.3 Mitochondrial degradation 
Since neurons are critically dependent on functional mitochondria, not only 
mitochondrial dynamics, axonal transport and fission-fusion, but also temporal-spatial 
removal of damaged mitochondria is another substantial component of the mitochondrial 
life cycle in neurons. Autophagy is a major catabolic process by which the cellular 
components including long-lived proteins and damaged organelles are degraded. During 
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autophagy, those cellular components are engulfed into double-membrane vesicles, 
autophagosomes, and then fused with lysosomes to form autolysosomes. Thereby, 
autophagy is proposed to play a clearing role in neurons by digesting and turning over 
dysfunctional cellular components, such as damaged mitochondria.  Mitophagy denotes 
the degradation specifically of mitochondria through this autophagic process. Although, 
so far, autophagy has been well-known for its role during starvation, emerging findings 
have suggested an intimate link between mitophagy and age-associated 
neurodegeneration.  
 Recent evidence implicates defective mitophagy in several neurodegenerative 
diseases. It is reported that elevated mitochondrial ROS production was found in a model 
of AD pathogenesis, and the deficiency of mitochondrial complexes I and IV is 
associated with amyloid  	
 (Caldwell et al., 2015; Lionaki et al., 2015). 
Additionally, studies in HD reveal that there is dysfunctional mitochondrial accumulation 
in the cytoplasm and the deficiency of autophagic recognition is also found in this disease 
model (Martinez-Vicente et al., 2010; Lionaki et al., 2015). Furthermore, it is notable that 
two PD related genes, PINK1 and Parkin, target depolarized, dysfunctional mitochondria 
for autophagic engulfment and degradation (Narendra et al., 2008; Matsuda et al., 2010; 
Narendra et al., 2010; Ashrafi et al., 2014; Lazarou et al., 2015). Although its underlying 
mechanism remains unclear, these findings suggest the impaired process of mitochondrial 
removal is significantly associated with the onset of several age-associated 
neurodegenerative diseases.  
It is still unclear whether dysfunctional mitochondria are selectively targeted for 
mitophagy and where the mitophagy event happens in neurons. However, recent evidence 
from disease model studies suggests an obvious connection between mitophagy and 
mitochondrial dynamics. For example, it has been reported that the fly model of 
Friedreich ataxia displayed disrupted axonal transport of mitochondria with the 
accumulation of senescent mitochondria in their neuromuscular junctions (NMJs) 
(Shidara and Hollenbeck, 2010). This clearly implicates that mitochondrial movement is 
associated with organelle turn over system in neurons. Thus, it is worth considering how 
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compromised neuronal mitophagy is affected by defective mitochondrial dynamics, such 






























1.2 Autophagosomes in Neurons 
 
Autophagy, which is described as   self-eating process is a conserved lysosomal 
degradation pathway. Mostly, autophagy has been studied in response to cellular stresses, 
such as starvation. However, it also reported that a basal level of autophagy is critical for 
neuronal survival (Hara et al., 2006; Mizushima et al., 2008). Since autophagy has been 
shown to be associated with various neurodegenerative diseases, recently, neurons are 
one of the cell types that are widely used for studying biogenesis of autophagic vacuoles, 
or autophagosomes (Larsen and Sulzer, 2002; Yue et al., 2009). It is reported that 
neuronal autophagy is reduced in a mouse model of AD, and autophagic deficiency 
ca  	
   
  (Pickford et al., 2008; Yue et al., 2009). In addition, 
studies from mouse and fly suggest that autophagic induction by inhibition of mTOR 
reduces polyglutamine expansion toxicity and enhances mutant huntingtin clearance in 
HD model (Ravikumar et al., 2004; Sarkar and Rubinsztein, 2008). Although studies are 
still limited, these findings nonetheless suggest a physiological role for autophagy in the 
etiology of neurodegenerative diseases. In this context, it cannot be ignored that the two 
PD related genes, PINK1 and Parkin, have been proposed to target dysfunctional 
mitochondria for the autophagosomal engulfment.  
 
 
1.2.1 Formation of autophagosome 
Generally, the autophagic process has been described as occurring in three different types: 
macroautophagy, microautophagy and chaperone-mediated autophagy. Since 
macroautophagy, hereafter referred to as autophagy, can eliminate large macromolecules 
and entire organelles by using several cytosolic vesicles, this process is mediated by a 
subset of molecular machinery to sequester vesicles and to form autophagosomes (Xie 
and Klionsky, 2007). Studies in yeast revealed that a number of autophagy-related (Atg) 
genes are engaged sequentially in a highly regulated manner (Tsukada and Ohsumi, 1993; 
Xie and Klionsky, 2007). In detail, autophagy involves a series of steps: phagophore 
formation, autophagosome elongation and lysosome fusion. These steps are controlled by 
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functional groups of proteins (Gelino and Hansen, 2012). First, an expanding cup-shaped 
double-membrane structure, called phagophore, is generated to enclose and isolate the 
cytoplasmic components. This formation of phagophore is known to be regulated by 
phosphatidylinositol 3-phosphate (PI3P)-binding complex. In this step, Atg9, a 
transmembrane protein that has been proposed to deliver lipids to the phagophore, is 
distributed by PI3P-binding complex. Once membrane nucleation and phagophore 
formation are completed, it is known that the Atg5/Atg12/Atg16 conjugation system is 
involved in phagophore expansion into the double-membrane structure of the 
autophagosome. The Atg5/Atg12/Atg16 complex mainly resides on the outer side of 
phagophore and decorates the expanding phagophore. This complex then associates with 
the Atg8/phosphatidylethanolamine (PE) conjugation system to grow and mature the 
autophagosomes. Growing autophagosomes can fuse with late endosomes and/or multi-
vesicular bodies (MVBs) to form hybrid organelles, called amphisomes. Lastly, the 
mature autophagosome that contains cargo eventually fuses with lysosome to become the 
autolysosome, and its cargos are degraded for recycling (Figure 1.4). During the process, 
most machinery proteins, except for Atg8, are gathered then released from the completed 
vesicle. Since Atg8 (LC3, mammalian homolog of yeast Atg8) widely associates with the 
autophagosomal membrane from phagophore formation through lysosomal fusion, Atg8 
(LC3) is often used as an experimental marker for autophagosomes. 
 
 
1.2.2 Autophagosomal axonal transport 
In neurons, less is known about the biogenesis, maturation and dynamics of 
autophagosomes. Like mitochondria, studies from neurons highly suggest that 
autophagosomes are uniquely regulated in axons and undergo MT-based transport 
(Hollenbeck, 1993; Maday et al., 2012). However, their axonal transport is mainly 
governed by dynein, MT-based retrograde motor protein (Maday et al., 2012; Cheng et 
al., 2015), so differs from the motility characteristic of other organelles, such as 
mitochondria (Morris and Hollenbeck, 1993) which exhibit both anterograde and 
retrograde movements in axons. Studies from primary dorsal root ganglion (DRG) 
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neurons showed that autophagosomes initiate in presynaptic nerve terminals and mature 
during dynein-dependent retrograde transport toward neuronal soma, where they fuse 
with lysosomes (Maday et al., 2012). They observed that autophagosomes initially 
display bidirectional motility at the distal tip of axon, however, in the middle of axon 
they develop pronounced retrograde transport without pauses or switches in direction. 
Interestingly, those retrograde-moving autophagosomes become increasingly acidified in 
axon near the cell body. In addition, study from cortical neurons also provides an 
evidence of unidirectional retrograde transport of autophagosomes along the axon (Lee et 
al., 2011). Therefore, these observations suggest the importance of axonal transport of 
autophagosomes for their life cycle in neurons: that the autophagosomes undergo 
maturation as they move retrogradely toward the neuronal soma.  
 So far, the underlying mechanism of how axonal autophasosomes display 
primarily retrograde transport is still not clear. Surprisingly, not only dynein and dynactin 
also the anterograde motors, kinesin-1 and kinesin-2, were co-purified with isolated 
autophagosomes by immunoblotting (Maday et al., 2012). This probably can explain the 
bidirectional movement of autophagosomes in the distal tip of axon, and further suggests 
the idea of an underlying mechanism involving competing motor proteins, dynein and 
kinesins, to give autophagosomal net movements. Indeed, it is thought that the axonal 
transport of autophagosomes is regulated by promoting dynein motor activity while 
inhibiting the activity of kinesins. In this regard, it is notable that the motor scaffolding 
protein JIP1 is proposed to be a coordinator for both dynein and kinesin-1 activity in 
autophagosomal transport (Fu et al., 2014). It is reported that JIP1 binds to LC3 
(mammalian homolog of Atg8) and broadly associates with autophagosomes. 
Interestingly, JIP1 can directly bind to the dynein activator dynactin as well as to the 
motor subunit of kinesin-1, kinesin heavy chain. Importantly, however, JIP1 cannot 
simultaneously bind to both dynactin and kinesin, instead it forms either a retrograde or 
an anterograde motor protein complex (Figure 1.5). In addition to JIP1, other studies 
proposed a role for htt and its adaptor protein, hutingtin-associated protein 1 (HAP1), as 
regulators in axonal transport of autophagosomes (Wong and Holzbaur, 2014b). Using 
live cell imaging in primary neurons, it has been shown that htt/HAP1 complex enhances 
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retrograde transport of autophagosomes. Interestingly, depletion of htt/HAP1 by RNAi 
knockdown significantly disrupts autophagosomal retrograde transport and leads to 
accumulation of autophagosomes with undegraded mitochondria. Consistently, neurons 
expressing pathogenic polyQ-htt also display disrupted autophagosomal dynamics. Since 
the defective transport of autophagosomes induced by polyQ-htt caused the accumulation 
of polyQ-htt aggregates as well, this clearly suggests that the axonal transport of 
autophagosome is tightly associated with cargo degradation for neuronal protection. 
Therefore, like mitochondrial axonal transport, the axonal transport of autophagosomes is 
























1.3 PINK1/Parkin Pathway in Mitochondrial Quality Control 
 
As described above, an understanding of mitochondrial transport, fission-fusion and 
mitophagy together provide a way to explain more fully the life cycle of mitochondria in 
neurons. Due to the potential distribution of functions among distant compartments, the 
regulation of the mitochondrial life cycle and maintenance of a robust functional 
  	 

     (Chen and Chan, 2009; Rugarli 
and Langer, 2012), are likely to be more complex in neurons in vivo than in cells of more 
modest dimensions. Recently, it has been proposed that mitochondrial dynamics and QC 
are functionally regulated by the proteins that are associated with PD. These proteins 

 -synuclein, DJ-1, leucine-rich repeat kinase 2 (LRRK2) and PINK1/Parkin 
(Henchcliffe and Beal, 2008).  
 Parkin is an E3 ubiquitin ligase that partially localizes to mitochondria (Clark et 
al., 2006) and controls mitochondrial fidelity via PINK1, PTEN-induced putative kinase 
1 (Park et al., 2006). Genetic analysis in Drosophila has demonstrated that PINK1 and 
parkin are functionally related. In Drosophila, a null mutant of PINK1 (PINK1B9) 
phenocopies the Parkin null mutants (park25). Both mutant flies showed shorted lifespan, 
apoptotic muscle degeneration, male sterility and disruptions of locomotion (Greene et al., 
2003). Importantly, over-expression of parkin was able to rescue these fly defects found 
in PINK1 mutants, whereas double mutants showed the same phenotypes as both of them 
alone. In addition, overexpression of PINK1 did not rescue the parkin defective 
phenotypes (Clark et al., 2006; Park et al., 2006). These findings clearly suggested that 
PINK1 and parkin function in the same pathway, and that parkin acts downstream of 
PINK1. For this reason, it is important to elucidate how the PINK1 and Parkin are 
functionally incorporated in mitochondrial quality control.  
 
 
1.3.1 Mitochondrial dynamics for organelle quality control 
Probably, digestion in lysosomes would be the final destination for the dysfunctional 
mitochondria and/or for their damaged components to be removed and recycled properly 
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in neurons. Here, mitochondrial axonal transport may help to send the damaged 
organelles to their final destination, while mitochondrial fission may sequester, and 
fusion may dilute, the senescent components in neuronal mitochondrial networks. As 
mitochondria display dynamic a life cycle in neurons, we expect their movement, 
morphological changes and degradation to be closely inter-related. Recently, the 
reciprocal interactions between these components of mitochondrial life cycle are 
becoming more appreciated, however, little is understood about their molecular 
mechanisms.  
 Remarkably, numerous studies indicate that mitochondrial axonal transport and 
their fission-fusion processes are closely inter-related. A study from cultured Drosophila 
neurons revealed that the myosin V depletion significantly increases number of elongated 
mitochondria in axons (Pathak et al., 2010). On the other hand, it is also reported that 
mitochondrial fission protein Drp1 effects on the proper distribution of mitochondria in 
Drosophila NMJs (Verstreken et al., 2005). In addition, studies from cultured DRG 
neurons suggested the involvement of the mitochondrial fusion protein Mfn2 in 
mitochondrial movement. Importantly, Mfn2 interacts with Miro and milton, key 
components that link mitochondria to MT-based kinesin motors (Baloh et al., 2007; 
Misko et al., 2010). Furthermore, a study from the axons of Drosophila larval neurons 
suggested that knockdown of Opa1 (mitochondrial inner membrane fusion protein) by 
RNAi impairs mitochondrial transport mainly in retrograde movements (Yu et al., 2016). 
Though the exact relationship between mitochondrial movements and morphological 
changes remains unclear, collected results suggest that these two components are tightly 
integrated in neurons: dysregulation of mitochondrial axonal transport affects organelle 
morphology (Pathak et al., 2010), while altered fission-fusion balance impairs axonal 
mitochondrial motility (Verstreken et al., 2005; Baloh et al., 2007; Misko et al., 2010; Yu 
et al., 2016). 
 Recently, an interesting idea describing the regulation of mitochondrial quality 
control via a vesicular trafficking pathway has been proposed. It has been reported that a 
subpopulation of mitochondria-derived vesicles (MDVs) can carry selected cargo to 
lysosomes under oxidative stress. This was surprising because of its independent role 
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from both mitochondrial fission and mitophagy. It was found that the formation of stress-
induced MDVs is Drp1 independent, and also the transport of MDVs to lysosomes is 
Atg5 and LC3 (Atg8) independent (Soubannier et al., 2012). Notably, rather, it was found 
that the generation of MDVs in response to mitochondrial oxidative stress is regulated by 
PINK1 and Parkin (McLelland et al., 2014). Thus, these findings suggest that the 
dysfunctional mitochondria can undergo comparably faster quality control via MDVs, by 
carrying selective cargo to lysosomes, whereas turnover of the entire organelle by 
mitophagy process is relatively slow.  
Indeed, PINK1/Parkin is known to function in mitochondrial dynamics broadly: 
not only in MDV generation, but also in mitochondrial axonal transport, in mitochondrial 
fission-fusion balance and in targeting dysfunctional mitochondria. Therefore, exploring 
the role of PINK1/Parkin in mitochondrial life cycle may provide a good guide to 
elucidate the intricate interrelationship of mitochondrial dynamics and to understand 
organelle quality control in neurons (Figure 1.6).  
 
 
1.3.2 PINK1/Parkin pathway in mitochondrial axonal transport 
Since the major compartments of the lysosome are found near nucleus, the axonal 
transport of mitochondria is thought to be highly linked with organelle turnover and 
quality control in neurons. As previously described (briefly in 1.1.1.2), PINK1 and Parkin 
are two proteins that are intensively studied for their potential linking of mitochondrial 
movement with organelle quality control.  
 The potential involvement of PINK1/Parkin in mitochondrial movement was first 
suggested by a biochemical assay which provided evidence of physical association 
between PINK1 and the Miro/milton complex (Weihofen et al., 2009). Later, Miro was 
also demonstrated to be a substrate of Parkin (Liu et al., 2012). It was reported that 
PINK1 phosphorylates Miro, which is critical for the subsequent activation of Parkin to 
this motor protein complex. Thus, the activation of PINK1/Parkin pathway promotes 
proteasomal degradation of Miro and consequently arrest mitochondria by detaching 
organelle from the MT-based motor. The idea of linker protein dissociation by 
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PINK1/Parkin pathway could explain the mitochondrial arrest caused by up-regulation of 
PINK1 or Parkin, and the enhanced mitochondrial movements caused by knockdown of 
PINK1 or Parkin (Wang et al., 2011). However, it is still not clear whether PINK1/Parkin 
selectively targets dysfunctional mitochondria in axonal transport so as to enhance 
organelle quality control. In this context, it is noteworthy that the results from 
immunoprecipitation show the interactions of PINK1 and Parkin with Miro upon 
mitochondrial depolarization by carbonyl cyanide m-chlorophenylhydrazone (CCCP) 
treatment.  
 The association of PINK1/Parkin with Miro caused by experimental 
mitochondrial depolarization is important for understanding a role of mitochondrial 
axonal transport in organelle quality control. Since Miro can also interact with Mitofusins 
(Misko et al., 2010), a proposed model for mitochondrial axonal transport and organelle 
quality control involving PINK1/Parkin is that PINK1/Parkin pathway arrests damaged 
mitochondria and prevents them from fusing with others, so that the damaged organelle 
can be quarantined in a fragmented state. If this is true, it probably supports the 
autophagosomal engulfment for mitophagy process by producing stationary and 
fragmented mitochondria (Figure 1.6).  
 
 
1.3.3 PINK1/Parkin pathway in mitochondrial fission and fusion 
Like mitochondrial axonal transport, the morphological changes of mitochondria by 
fission-fusion are also thought to be related to organelle turnover and quality control in 
neurons. Specifically, it is thought that fission is responsible for sequestration and 
isolation of dysfunctional mitochondria thus may help to promote their degradation. On 
the other hand, fusion seems to be required for dilution of damaged mitochondrial 
materials to complement and protect the organelle functions. Indeed, PINK1 and Parkin 
have been also reported to function not only in the mitochondrial transport machinery, 
but also in mitochondrial fission-fusion. Thus, a better understanding of these two PD 
related genes is needed if we are to determine the role of mitochondrial fission-fusion 
processes in the organelle quality control. 
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 How does the PINK1 and Parkin pathway regulate mitochondrial morphology in 
organelle quality control? Genetic studies in Drosophila flight muscle revealed that 
knocking out either protein caused swollen and enlarged mitochondria (Clark et al., 2006; 
Poole et al., 2008). Although it still remains unclear that the modulation of mitochondrial 
morphology by PINK1/Parkin seems different from mammalian cells, studies in 
Drosophila suggest that PINK1 and Parkin seem to promote mitochondrial fission and/or 
inhibit mitochondrial fusion. Importantly, mitochondrial morphological defects caused by 
PINK1/Parkin depletion were restored by over-expression of the fission protein Drp1 or 
down-regulation of fusion proteins Mfn2 and Opa1 (Poole et al., 2008). Though the 
epistatic relationship of PINK1/Parkin to the mitochondrial fission and fusion may not be 
direct, these observations clearly indicate a genetic interaction between PINK1/Parkin 
and mitochondrial fission-fusion machineries. 
 Interestingly, a recent study in mouse cardiac myocytes proposes that the Mfn2 is 
a mitochondrial receptor for Parkin recruitment (Chen and Dorn, 2013). In this study, it is 
reported that phosphorylation of Mfn2 by PINK1 promotes the interaction between Mfn2 
and Parkin. In addition, Mfn2 knockout prevented Parkin translocation to the depolarized 
mitochondria under carbonyl cyanide 4-phenylhydrazone (FCCP) treatment. Since the 
depletion of Mfn2 subsequently suppressed mitophagy events (Chen and Dorn, 2013), 
this suggests a potential mechanism by which Mfn2 can mediate PINK1 and Parkin for 
mitochondrial quality control (Figure 1.6).  
 
 
1.3.4 PINK1/Parkin pathway in mitophagy 
So far, it is not clear whether PINK1 and Parkin specifically target dysfunctional 
mitochondria for autophagosomal engulfment and lysosomal degradation in neurons. 
Recently, however, numerous studies in non-neuronal cells provide evidence of 
PINK1/Parkin involvement in experimentally-depolarized, dysfunctional mitochondria 
(Narendra et al., 2008; Jin et al., 2010; Matsuda et al., 2010; Narendra et al., 2010; 
Ashrafi et al., 2014; Lazarou et al., 2015). Thus, exploring how PINK1 and Parkin play a 
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role in mitochondrial turnover is required for better understanding mitochondrial quality 
control in neurons under normal physiological conditions.  
 Normally, PINK1 is known to be cleaved by mitochondrial translocase of the 
inner membrane (TIM) and presenilin-associated rhomboid-like protease (PARL) which 
reside in the mitochondrial inner membrane, so that it is kept in an inactivate state (Jin et 
al., 2010). PINK1, however, can be stabilized and thus accumulate on the outer 
membrane of mitochondria upon organelle depolarization, there to subsequently recruit 
Parkin to the mitochondrial surface (Jin et al., 2010; Matsuda et al., 2010; Narendra et al., 
2010). In addition, knockdown or knockout of PINK1 results in failure to translocate 
Parkin to mitochondria even under CCCP treatment (Matsuda et al., 2010; Narendra et al., 
2010). These observations clearly demonstrated that Parkin translocation to the 
depolarized mitochondria is mediated by PINK1.  
 PINK1 phosphorylates either ubiquitin (Ub) or Parkin to trigger translocation of 
Parkin and to promote ligase activity of Parkin. Translocation and activation of Parkin on 
depolarized mitochondria leads to further ubiquitination of mitochondrial outer 
membrane proteins, such as Miro and Mfn2. It is believed that this stepwise process 
driven by PINK1/Parkin leads to recruitment of the autophagosomal machinery for 
engulfment and removal of damaged mitochondria. Still, adaptors that bind to ubiquitin 
chains on damaged mitochondria for the PINK1/Parkin-mediated autophagic process is 
not known. However, several proteins are proposed to play a role in PINK1/Parkin-
mediated mitophagy as an autophagic receptor. It was suggested that Parkin-dependent 
mitophagy requires the ubiquitin-autophagic adaptor p62. In this study, it was identified 
that voltage-dependent anion channel 1 (VDAC1) is a target protein of Parkin activity in 
response to mitochondrial depolarization (Geisler et al., 2010). Recently, two other 
candidates, optineurin and NDP52, have been shown to mediate PINK1/Parkin-
dependent mitophagy in the absence of p62 (Wong and Holzbaur, 2014a; Lazarou et al., 
2015). In addition, however, contradictory findings were also reported in the 
identification of autophagic receptors for PINK1/Parkin-mediated mitophagy. Ambra1, 
an activating molecule in beclin1-regulated autophagy, is an example. A study in cultured 
cells demonstrated that the endogenous Ambra1 and Parkin are coimmunoprecipitated 
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and their interaction was pronouncedly increased under mitochondrial depolarization 
(Van Humbeeck et al., 2011). Contrary to this, however, it was also reported that Ambra1 
induces the LC3-dependent mitophagy process under antimycin A (Ant A) treatment in 
Parkin-deficient cell lines (Strappazzon et al., 2015). Though there are still uncertain and 
contradictory observations in identification of PINK1/Parkin-mediated autophagic 
receptor, the suggested proteins activated by PINK1/Parkin are recruited to the 
depolarized mitochondria prior to the formation of LC3-positive autophagosomes. 
Therefore, these recent findings provide several possible links between PINK1, Parkin 
and the selective mitochondrial degradation via autophagosomes in neurons.  
 It is important to note that the previous studies demonstrating the role of PINK1 
and Parkin in mitochondrial turnover have been carried out largely using chemically-
uncoupled mitochondria in immortalized cell lines (Narendra et al., 2008; Geisler et al., 
2010; Matsuda et al., 2010; Narendra et al., 2010; Van Humbeeck et al., 2011; Wong and 
Holzbaur, 2014a; Lazarou et al., 2015; Strappazzon et al., 2015). This actually raises the 
issue of how and whether the PINK1/Parkin pathway regulates neuronal mitochondrial 
autophagy in vivo under normal physiological conditions. In addition, since 
mitochondrial QC includes not only autophagy, but the interrelated processes of transport, 
biogenesis, fission and fusion (Chen and Chan, 2009), broader regulatory effects of 
PINK1/Parkin activity may occur. In particular, the compartmentalization of neurons 
raises the question of whether different components of regulation of the mitochondrial 









CHAPTER 2. MATERIAL AND METHODS 
 
 
2.1 Materials and Model System 
 
2.1.1 Reagents 
Hemolymph-like buffer (HL6 buffer containing 0.6 mM CaCl2 and 4 mM L-glutamate), 
CO2, dH2O, VALAP (Vaseline, Lanolin and Paraffin mixture), 70% ethanol, DMSO - 
dimethyl sulfoxide (Sigma, #D2650), TMRM - tetramethylrhodamine methyl ester (Life 
Technologies Molecular Probes, #T668), agarose (Invitrogen, #15510-019), Triton X-100 
(Sigma, #9002-93-1), PBS, Sparkle glass cleaner, Endotoxin-free sterile water (VWR, 
#16750-098), Schneider s medium (Gibco, #21720-024), FBS (Atlanta Biologiclas, 
#S11150H), Pen-Strep (50 g/ml of penicillin with 50 g/ml of streptomycin), 
Ca2+/Mg2+-free saline, collagenase (Sigma,#C2674), concanavalin A (Sigma, #C0412), 
H2O2 (Mallinckrodt, #7722-84-1), antimycin A (Sigma, #A8674), paraformaldehyde, 




Sylgard plate, 3 concavities glass slide, two pairs of fine paint brushes (Daler Rowney, 
#00), Vannas Spring Scissors - Straight/Sharp/8 cm/3 mm Cutting Edge (Fine Science 
Tools, #15000-00), two pairs of Dumont #5 Forceps - Standard 
Tips/Straight/Dumostar/11 cm (Fine Science Tools, #11295-00), Dumont #7 Forceps - 
Inverted/Curved/11.5 cm (Fine Science Tools, #11274-20), Minutien Pins - Stainless 
Steel/0.1 mm Diameter (Fine Sciences Tools, #26002-10), dental wax (Surgident, 
#50092189), double-sided tape (Scotch, #137DM-2), cotton swab (Puritan, Cotton
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 Tipped Applicators), siliconized p200 pipette tips (VWR, #53503-790), 1.5 ml 
microfuge tube (VWR, #20901-551), 25 X 75 mm glass slides (Rite-on Gold Seal Micro 
Slides Pre 
Cleaned, #3050), 25.4 X 76.2 mm single concavity glass slides (Pearl, #7103), 24 X 40 
mm cover glasses (VWR, #16004-306), 22 X 22 mm cover glasses (VWR, #48366-067), 
35 X 10 mm tissue culture dishes (Falcon, #353001), Mini-protean TGXTM gels (Bio-Rad, 
#456-1033), BCATM protein assay kit (Pierce, #23227), Mini trans-blot cell (Bio-Rad, 
#1703989), Nitrocellulose membranes (Thermo Sci., #88025).  
 
 
2.1.3 Drosophila Melanogaster 
All flies were reared in polystyrene vials (25 X 95 mm) with standard cornmeal agar 
medium. Fly stocks were maintained at 25oC room temperature and 50% humidity with a 
























#1 D42-Gal4>UAS-mitoGFP (III)   
#2 w1118   
#3 D42-Gal4>UAS-mitoGFP/+ (III) #1 #2 
#4 park25, D42-Gal4/TM6B (III)   
#5 park25,UAS-mitoGFP/TM6B (III)   
#6 park25, D42-Gal4/park25,UAS-mitoGFP (III) #4 #5 
#7 UAS-ParkinC2/CyO (II); park25, D42-Gal4/TM6B (III)   
#8 UAS-ParkinC2/CyO (II); park25, UAS-mitoGFP/TM6B (III)   
#9 UAS-ParkinC2 (II); park25, D42-Gal4/park25, UAS-mitoGFP (III) #7 #8 
#10 UAS-RFPatg8 (II); D42-Gal4>UAS-mitoGFP (III)   
#11 UAS-RFPatg8 (II); +/TM6B (III)   
#12 UAS-RFPatg8 (II); D42-Gal4>UAS-mitoGFP/+ (III) #10 #11 
#13 UAS-RFPatg8 (II); park25, D42-Gal4/TM6B (III)   
#14 UAS-RFPatg8 (II); park25, UAS-mitoGFP/TM6B (III)   
#15 UAS-RFPatg8 (II); park25, D42-Gal4/park25, UAS-mitoGFP (III) #13 #14 
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Table 2.1 continue 
#16 dpr-Gal4/CyO (II)   
#17 UAS-mitoGFP/gla (II); +/TM6B (III)   
#18 dpr-Gal4/UAS-mitoGFP (II) #16 #17 
#19 park1/TM6B (III)   
























2.2 Drosophila Preparation for In Vivo and In Vitro Conditions 
 
2.2.1 Fly larval dissection for in vivo observation 
Procedures of larval dissection and mounting were performed essentially as previously 
described (Devireddy et al., 2014). Wandering late third instar larvae were collected for 
larval dissection, and washed gently by distilled water in 3 concavities glass slide to 
remove the remaining cornmeal agar medium. Washed larvae were placed on a Sylgard 
plate with the dorsal side up, and fixed with Minutien Pins at posterior and anterior ends 
of body. Pinned larvae were dissected with a Vannas Spring Scissors from posterior to 
anterior along the dorsal body wall in a puddle of HL6 buffer containing 0.6 mM of 
CaCl2 and 4 mM of L-glutamate. Fat bodies and intestines were then removed gently 
with Dumont #5 Forceps to reveal the intact ventral ganglion, segmental nerves and 
neuromuscular junctions (Pilling et al., 2006; Louie et al., 2008; Shidara and Hollenbeck, 
2010). The dissected and cleaned larva was unpinned from Sylgard plate and gently 
arranged dorsal side up on a 25 X 75 mm glass slide using a fine paint brush. The 
dissected larva was then covered by a 24 X 40 mm cover glasses using dental wax as a 
spacer to form a chamber. The chamber was filled with ~ 120     	
 
sealed with VALAP for imaging. Segmental nerves, branched thin axons, ventral ganglia, 
and neuromuscular junctions from the dissected late third instar larva (Figure 2.1) were 
monitored for in vivo observation. To insure normal in vivo conditions of the nervous 
system, larval dissection was performed in no longer than 5 minutes and larval motor 
neurons were observed within 20 minutes of dissection (Shidara and Hollenbeck, 2010; 
Devireddy et al., 2014).  
 
 
2.2.2 Adult fly wing preparation for in vivo observation 
Hatched flies were synchronized by age to collect the 5-day-old adults for wing 
preparation, and paralyzed on a CO2 anesthetizing pad. The fly wings were visualized 
under a regular dissecting stereomicroscope, and prepared on a Sylgard plate. In all 
experiments, only the right wing from the female adult was used. The wing preparation 
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was performed to serve the experimental purpose using one of the two methods described 
below (Fang et al., 2013): live imaging of the wing nerve, or quick imaging of detached 
wings. 
Live imaging of the wing nerve: paralyzed 5-day-old adult flies were collected, 
and their left wings were cut at the end of wing root with a Vannas Spring Scissors to 
avoid a hindrance to right wing observation. Prepared flies were then mounted on 25.4 X 
76.2 mm single concavity glass slides. Using a fine paint brush, flies were posed ventral 
side up in the concave well, and their bodies were fixed in place with 2% agarose. The 
wing was placed flat and extending out from the body. Concave glass slides with 
prepared fly samples were cover by 24 X 40 mm cover glasses using dental wax as a 
spacer to form a chamber. 
Quick imaging of detached wings: paralyzed 5-day-old adult flies were collected, 
and their right wings were cut at the end of wing root with a Vannas Spring Scissors to 
preserve whole nerve tract along the humeral crossvein with the lateral vein and costal 
vein (Fang et al., 2012). Severed wings were pretreated with detergent (20%, Triton X-
100 in dH2O) to avoid trapping air bubbles, and briefly rinsed with 1X PBS. Prepared 
wings were then mounted on 25 X 75 mm glass slides with the dorsal side up, and 
covered by 24 X 40 mm cover glasses using dental wax as a spacer to form a chamber. 
The chamber was filled with PBS and sealed with VALAP for imaging. To insure normal 
in vivo conditions of the wing nervous system, images were taken within 10 minutes of 
scission.  
Neuronal cell bodies from fly wing were observed at the distal part of lateral vein 
1 (Figure 2.2, from 3 to 4), and axons of humeral crossvein (Figure 2.2, from 1 to 2) from 




2.2.3 Primary neuronal cell culture for in vitro experiments 
Crawling late third instar larvae were selected, sterilized briefly with 70% ethanol and 
rinsed in dH2O. Schneider s medium containing 10% FBS and 0.5% Pen-Strep was 
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prepared, and the washed larvae were transferred to a drop of Schneider s medium on 
Sylgard plate. Brain lobes and ventral ganglia (CNS) were taken from larvae and 
transferred into 1.5 ml microfuge tubes containing ~500  l of Schneiders medium. 5 ~ 7 
sets of CNS were collected per each tube, and centrifuge at 300 g for 5 minutes. 
Supernatant was removed without disturbing the pellet from tubes and 500  l of 
Ca2+/Mg2+-free saline with 0.7 mg/ml of collagenase was added to incubate the CNS for 1 
hour at room temperature. Incubated CNS was then dissociated into individual cells by 
siliconized pipette triturating in 500  l of Schneiders medium. After dissociation, ~ 250 
 l of cell solution was transferred to 22 X 22 mm cover glass that coated with 20  g/ ml 
of concanavalin A in a 35 X 10 mm tissue culture dish, and incubated 1 hour for cell 
adhesion. After 1 hour of incubation, 2 ml of Schneiders medium was added and culture 
dishes were incubated at 22oC in humidified chamber for ~96 hours to allow neurons to 
extend their processes. After 96 hours, medium was changed to 2 ml of new Schneiders 
medium prior to imaging. Prepared 22 X 22 mm cover glasses with cultured neurons 
were flipped over using Dumont #7 Forceps, and mounted on 25 X 75 mm glass slides. 
Glass slides were prepared by attaching double-sided tape as a spacer to form an imaging 
chamber. Formed chamber was filled with ~ 100   of Schneiders medium, and sealed 
with VALAP. Using a cotton swab with Sparkle glass cleaner, the sealed cover glasses 









Figure 2.1 Dissected late third instar larva expressing mito-GFP in motor neurons. 
Mitochondrial movements are monitored at three different regions in the axons of 
segmental nerves (SNs): proximal (A2), middle (A4), and distal (A7). Cell bodies in the 












Figure 2.2 Drosophila s wing morphology and axonal mitochondria. Dorsal view of 
right wing and landmark positioning. LV: longitudinal vein, HCV: humeral crossvein, 

















2.3 Imaging by Confocal Microscopy 
 
All imaging was performed using a laser scanning confocal microscope (LSCM, Nikon 
C1 on an Eclipse 90i microscope). Time lapse images, kymographs (Figure 2.3) and 3D 




2.3.1 Time lapse images without photo-bleaching 
To analyze organelle movements in larval motor neurons, time lapse images were 
acquired without photo-bleaching from the longest segmental nerve; mitochondrial 
movements were analyzed in three different regions (A2, A4 and A7), while autophagic 
vacuole movements were analyzed in the middle (A4) of the segmental nerve (Figure 2.1).  
Time lapse confocal images were obtained using 5% laser power with a 488 nm line for 
mito-GFP and 10% laser power with a 561 nm line for RFP-Atg8 through the smallest 
pinhole (30   Since images were acquired by a 60X oil-immersion objective and 
generated by 4X field zoom at 512 pixel resolution, the region imaged for segmental 
nerves was 51.2   in length with varying height. The frames for individual channels 
(513/30 for mito-GFP and 590/50 for RFP-Atg8) were obtained at 1 second time intervals 
for 2 minutes. Representative kymographs were generated from the acquired frames 
(Figure 2.3, A and C) to observe and confirm general movements of organelles. To 
ensure live physiological conditions of the larval nervous system, time lapse images were 
taken within 10 minutes of individual animal.  
 
 
2.3.2 Time lapse images with photo-bleaching 
Mitochondrial movements were monitored with photo-bleaching from the middle (A4) of 
the longest segmental nerve to scrutinize their movements without interference from the 
abundant, bright, stationary mitochondria. Time lapse confocal images were obtained 
using 5% laser power with a 488 nm band, and the full intensity (100% laser power) of 
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488 nm light from the confocal laser at 1 frame scan per second for 30 seconds was used 
to illuminate the region of interest. Images were acquired by a 60X oil-immersion 
objective and generated by 4X field zoom at 512 pixel resolution with a regional photo-
bleaching. An area box with 30   fixed length was drawn in the middle of the assigned 
segmental nerve to give regional photo-bleaching; 30   length illumination within 51.2 
  of segmental nerves. Time course images were obtained at a rate of 1 frame every 2 
seconds for 5 minutes, and representative kymographs were generated from the acquired 
frames (Figure 2.3, B and D). Note that photo-bleaching eliminates the mito-GFP signals 
from the stationary mitochondria, allowing the visualization of the movement of 
individual mitochondria clearly. To ensure the live physiological conditions of the larval 
nervous system, time lapse images with photo-bleaching were taken within 20 minutes of 
individual animal.  
 
 
2.3.3 Z-stack images for 3D structure 
Images of motor neuronal cell bodies in ventral ganglion (Figure 2.1) were acquired with 
confocal z-stack frames to construct the 3 dimensional structures. 5% laser power with a 
488 nm line was used for mito-GFP and 10% laser power with a 561 nm line was used 
for RFP-Atg8 through the smallest pinhole (30   by a 60X oil-immersion objective. 
Confocal z-stack images were generated by Microscope 90i Z-Drive, and the frame with 
focused nucleus set as the Ref (Figure 2.4, A). To cover the volume of the cell bodies, set 
the number of Steps as 100 with 0.05   Step Size to get the Range of 5  ; 2.5   
Range above and below the Ref, to Top and Bottom, respectively. 100 frames of confocal 
images were then reconstructed to 3 dimensions using Volume View generation of NIS-
Elements AR 3.2 software. Maximum Intensity Projection was selected for blending the 
signals, and Bounding Box was selected for visualizing axes. To get the single cell body 
structure, images were cropped and built from 20   (X, height) by 20   (Y, width) 







Figure 2.3 Mitochondrial transport without and with photo-bleaching. (A), 
Representative frames at 30 second intervals spanning 2 minutes under non-bleached 
conditions. Red arrowheads represent anterograde moving mitochondria, while blue 
arrowheads represent retrograde moving mitochondria. (B), Representative frames at 60 
second intervals spanning 5 minutes under photo-bleached condition. Individual moving 
mitochondria are marked as red arrowheads (1 and 2) for anterograde and as blue 
arrowheads (3 and 4) for retrograde. (C), Representative kymograph from (A). (D), 









Figure 2.4 Z-stack structure image of organelle from motor cell body. (A), 
Representative plane image of mitochondria with autophagic vacuoles in motor cell body. 
Mitochondria are visualized by mito-GFP (green), while autophagic vacuoles are 
visualized by RFP-Atg8 (red). (B), 3 dimensional structure image of mitochondria with 
autophagic vacuoles that are reconstructed from (A). 100 frames are obtained to construct 

















2.4 Analysis of Organelle Movements 
 
For understanding axonal organelle transport, analysis and quantification of moving 
parameters were performed essentially as previously described (Devireddy et al., 2014). 
 
 
2.4.1 Mitochondrial movements 
Axonal transport ofmitochondria was analyzed based upon the time lapse images of mito-
GFP from the longest segmental nerves. Flux was measured from three different regions 
(A2, A4 and A7) of segmental nerves, and NIS-Elements AR 3.2 software was used for 
measurement. Mitochondrial flux was measured for both anterograde and retrograde 
movement by observing the number of moving mitochondria passing a defined point per 
unit time over 2 minutes. To define the observing point, a vertical line was drawn in the 
middle of segmental nerve using Insert Line by Annotations function. Velocity was 
measured from three different regions (A2, A4 and A7) of segmental nerves, and manual 
tracking of ImageJ software was used for measurement. Mitochondrial velocity was 
measured from a run (continuous movements of more than 3 seconds duration) in one 
direction. One pixel represents 0.1   in the collected images, and only net velocities 
greater than 0.1  /sec or less than - 0.1  /sec for at least three consecutive frames 
were selected as bona fide anterograde and retrograde transport, respectively. During 2 
minute time lapse movies, only mitochondria that moved for more than 60 seconds were 
considered for velocity analysis. At least 5 anterograde and 5 retrograde mitochondria 
were tracked respectively from each individual animal. Percent of movement was 
measured from three different regions (A2, A4 and A7) of segmental nerves, and ImageJ 
software was used for quantification. The % of mitochondria moving and stationary was 
measured from the total population of mitochondria within a field. Since the population 
of mitochondria within the assigned axonal regions included a changing set of moving 
mitochondria, the second frame of each movie was selected for designating the total 
mitochondrial population. Mitochondria in the population were categorized and marked 
as anterograde, retrograde or stationary by the Cell Counter plugin in ImageJ to quantify 
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the percentage of moving and stationary mitochondria in segmental axons. Duty cycle 
was measured from three different regions (A2, A4 and A7) of segmental nerves, and 
ImageJ software was used for quantification. After determining the runs and pauses by 
ImageJ, mitochondrial duty cycle was calculated for moving mitochondria based on 
observing their movement or pause time over the observation interval. The percentage of 
the time that mitochondria moved in each particular direction or paused was quantified. 
Only mitochondria that moved for more than 60 seconds were considered for duty cycles, 
and at least 5 anterograde and 5 retrograde moving mitochondria were selected 
respectively from individual animals. Run length was measured from three different 
regions (A2, A4 and A7) of segmental nerves, and ImageJ software was used for 
calculation. After determining the runs and pauses by ImageJ, mitochondrial run length 
was defined as the distance per individual run, between stops. Mitochondrial net runs in 
the dominant direction only for both anterograde and retrograde movement were used for 
the run length measurement. To calculate the average of run length, the total distance of 
runs from a moving mitochondrion was divided by the number of runs. At least 5 
anterograde and 5 retrograde moving mitochondria were considered respectively from 
individual animals. Number of steady-state movers was measured from the middle (A4) 
of segmental nerves with photo-bleaching, and NIS-Elements AR 3.2 software was used 
for analysis. Every 30 seconds over 5 minutes, number of steady-state moving 
mitochondria was quantified from the 30   bleached regions within 51.2   of 
segmental nerves. To define the observing point, a red box that covers the bleached 
region was drawn using Insert Rectangle by Annotations function. Note that the numbers 
of mitochondria moving into the bleached regions become equal in number of entry and 
exit within a certain period of time. 
  
 
2.4.2 Autophagic vacuole movements 
Axonal transport of autophagosomes was analyzed based upon the time lapse images of 
RFP-Atg8 signals from the middle (A4) of the longest segmental nerves. 
Autophagosomal flux was measured as stated above (2.4.1) by using NIS-Elements AR 
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3.2 software. Since some diffuse RFP-Atg8 signal was seen throughout the axonal 
cytosol, only vacuoles above an assigned threshold intensity (1000 on a 12-bit scale) 




2.5 Determination of Organelle Density and Co-localization 
 
2.5.1 Mitochondrial density in motor axons 
MetaMorph version 7.6.5 software was used to measure the mitochondrial density in 
axons based on the intensity of the mito-GFP signal (Devireddy et al., 2014). Density was 
defined as the total pixels occupied by mitochondria within the assigned axonal regions. 
To reduce the noise and sharpen the original images, Low-Pass2 and Laplace filters were 
consecutively used in MetaMorph software. Then, the images were converted to binary 
forms via Binary Operations with 400 minimum intensity thresholds on a 12-bit scale of 
0 - 4095 to clarify the shape of the mitochondrial boundary. To retain their original form, 
the binarized images were processed using Dilate with 4 pixel Neighborhood using 
MetaMorph. From the binarized and dilated images, the Integrated Intensity 
measurement was used to quantify the area occupied by mitochondria. Axons from 
different regions (A2, A4 and A7) of larval segmental nerves (Figure 2.5, A) and axons 
of the humeral crossvein from the adult fly wing arch (Figure 2.5, B) were monitored to 
analyze the density of axonal mitochondria. To determine mitochondrial density in larval 
segmental nerves, the second frame of each movie was selected for the quantification.  
 
 
2.5.2 Organelle density in motor cell bodies and neuromuscular junctions 
NIS-Elements AR 3.2 software was used to analyze the area and to quantify the organelle 
density from the assigned regions, cell bodies or neuromuscular junctions. Density was 
defined as the area that occupied by organelles of interest, mitochondria or 
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autophagosomes, divided by the total area of the assigned regions. 515/30 (mito-GFP) 
channel was used for measuring mitochondrial area, whereas 590/50 (RFP-Atg8 or anti-
HRP) channel was used for measuring the area of autophagic vacuoles or synaptic 
boutons respectively. The density of mitochondria was quantified both from motor cell 
bodies and neuromuscular junctions, whereas density of autophagosomes was quantified 
only from motor cell bodies.  
 Organelle density in motor cell bodies: in each cell body, the Polygonal ROI tool 
was used to draw a region around the cell body and the area occupied by assigned 
organelles, mitochondria or autophagosomes, was calculated as a fraction of total area 
(Figure 2.6, A). The images were converted to representative thresholded versions to 
clarify the shape of the organelle boundaries. Minimum intensities varied while 
maximum threshold intensity was fixed as 4095 on a 12-bit scale. At least 5 cell bodies 
were analyzed from individual animals.  
 Mitochondrial density in neuromuscular junctions: neuromuscular junctions were 
selected between muscles 7 (M7) and 6 (M6) from the middle (A4) of the body wall 
(Figure 2.6, B). In each neuromuscular junction, the Polygonal ROI tool was used to 
draw a region around the synaptic boutons and the area covered by mitochondria was 
calculated and divided by the total area using ROI Area (Figure 2.6, C). The images were 
converted to representative thresholded versions (400 minimum intensity for 
mitochondria, and 200 minimum intensity for anti-HRP staining) to clarify the shape of 
the organelle boundaries. At least 5 synaptic boutons were selected from individual 
neuromuscular junctions for the mitochondrial density measurement.   
 
 
2.5.3 Co-localization of mitochondria with autophagic vacuoles 
Mitochondrial co-localization with autophagic vacuoles was quantified by NIS-Elements 
AR 3.2 software. Motor neuronal cell bodies and axons from dissected larvae were 
selected to analyze the organelle co-localization. Intensity Profile from two channels, 
513/30 (mito-GFP) and 590/50 (RFP-Atg8), was used to analyze the co-localization. Line 
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scans of the images were used to indicate the signal Intensity Profile of mitochondria and 






















Figure 2.5 Density of mitochondria in motor axons. (A), Representative confocal 
fluorescence image (a ) and converted binary image (a  ) of mitochondria from the axon 
of A4 segmental nerves. (B), Representative confocal fluorescence image (b ) and 
converted binary image (b  ) of axonal mitochondria from the humeral crossvein of 5-
day-old adult fly wing. Mitochondrial density is quantified from the images of (a  ) and 








Figure 2.6 Density of organelles in motor cell bodies and neuromuscular junctions. 
(A), Representative images of motor cell bodies for organelle density measurements. 
Signal (mito-GFP and RFP-Atg8) are thresholded (a ) and the boundaries of cell bodies 
are designated (a  ) for density measurement. (B), Neuromuscular junctions are 
monitored from the middle (A4) segmental nerves between muscle 7 (M7) and 6 (M6). 
Mitochondria in neuromuscular junction are visualized by mito-GFP (b ). (C), 
Representative image of neuromuscular junction for mitochondrial density measurement. 
Mitochondria are visualized by mito-GFP (green) expression and motor synaptic boutons 
are stained with anti-HRP (red). The red box indicates higher magnification images (c ) 
of synaptic boutons and mitochondria for the quantification of area.  
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2.6 Analysis of Mitochondrial Morphology 
 
2.6.1 Measurement of mitochondrial length 
The length of axonal mitochondria was determined by manually measurement, using NIS-
Elements AR 3.2 software. Non-overlapping axonal mitochondria were selected from 
cultured neurons or larval segmental nerves. Stationary and moving (both anterograde 
and retrograde) axonal mitochondria from three different regions (A2, A4 and A7) of 
segmental nerves were separately considered for the length measurement. Within the 
collected frames of time lapse images, the frame that contained the best focused non-
overlapping mitochondria was selected. From these frames, the individual coordinates of 
mitochondria were used for the length measurement. The designated coordinates were 
measured using Length tool with 2 Points by Measurements function. Since 1 pixel 
represents 0.1   in the NIS-Elements AR 3.2 software images, the minimum standard 
distance unit was 0.1   (Figure 2.7, a). To determine the boundary of mitochondria, 
images were thresholded at a standard intensity of 200 to identify pixels belonging to 
mitochondria. At least 5 each of stationary, anterogradely and retrogradely mitochondria 
were selected respectively from individual animals and 10 mitochondria were selected 
from each single culture dish for the mitochondrial length measurement.  
 
 
2.6.2 Measurement of mitochondrial area 
The area of axonal mitochondria in segmental nerves was measured from the binarized 
images by MetaMorph version 7.6.5 software. Non-overlapping axonal mitochondria 
from three different regions (A2, A4 and A7) of segmental nerves were selected and 
considered for the area measurement. From the binarized images, individual polygons 
were automatically designated by Create Regions Around Objects function (Figure 2.7, 
b). Integrated Intensity and Area were selected from Configure to measure the area of 
each polygon. Only polygons that represented single mitochondria were considered. At 




2.6.3 Analysis of 3D structure of mitochondria 
3 dimensional structures of mitochondria were analyzed in motor cell bodies from 
dissected larvae. Generated 3 dimensional structures from the confocal z-stack frames 
(2.3.3) were played and monitored through Show Volume View in NIS-Elements AR 3.2 
software. Axes were visualized by Show Axis, and the volume was clarified by Show Box 
to give an outline of coordinates. From Volume View, Move Orthogonal Cropping Plane 
and Colocalization were played to analyze the organelle (mitochondria (mito-GFP, 
515/30) and autophagic vacuoles (RFP-Atg8, 590/50)) co-localization. To analyze 
mitochondrial structure, images were rotated using the Rotation tool along the X, Y and Z 
axes. Mitochondrial structure was categorized into 4 different phenotypes; fragmented, 
wild-type, tubular and hyper-fused. Mitochondrial morphological analyses were 

















Figure 2.7 Length and area measurement of axonal mitochondria. The red box in a 
confocal fluorescence image is enlarged in (a) to show mitochondrial length 
measurements performed using NIS-Elements software. Polygons in (b) are designated by 
MetaMorph software from the binary image to measure the area of mitochondria. (Figure 




















2.7 Determination of Mitochondrial Inner Membrane Potential 
 
Tetramethylrhodamine methyl ester (TMRM), a lipophilic cationic fluorescent dye, was 
used for the determination of mitochondrial transmembrane potential both, in vivo 
(Devireddy et al., 2014) and in vitro (Verburg and Hollenbeck, 2008). Thin neurons and 
neuromuscular junctions adjacent to the middle segmental nerves in larval A4 segment 
and projected axons of primary cells were selected for measuring neuronal mitochondrial 
membrane potential under in vivo and in vitro conditions. TMRM was prepared as a 20 
µM working solution by dissolving in sterile filtered DMSO, and the prepared working 
solution was diluted into medium   	 
	 	  for the 
experiment. 200 nM TMRM in prepared medium was added to the dissected larvae or 
cultured cells for 20 minutes, then replaced with 50 nM TMRM for imaging. Images 
were obtained sequentially using 5% laser power, 488 nm excitation, for mito-GFP and 
5%, 561 nm excitation for TMRM. Only non-overlapping axonal mitochondria were 
considered for quantification. 
 Mitochondrial inner membrane potential was quantified using NIS-Elements AR 
3.2 software. The ratio of mitochondrial fluorescence intensities (Fm) over cytoplasmic 
fluorescence intensities (Fc) was used to estimate mitochondrial membrane potential 
 m, Fm/Fc) (Verburg and Hollenbeck, 2008; Shidara and Hollenbeck, 2010; Devireddy 
et al., 2014). To clarify the boundaries of axonal mitochondria, images were thresholded 
at an intensity of 400 to identify pixels belonging to mitochondria. Mitochondria were 
designated by Polygonal ROI for measuring Fm, and two square boxes (7 by 7 pixels) 
adjacent to the assigned mitochondrion were drawn by Rectangular ROI within cytosol 
for Fc measurement. Fluorescence intensity of Fm and Fc were determined from 
MeanIntensity with ROI Area, selected by ROI Data. To estimate m, Fc was calculated 
as the mean of two MeanIntensity from the square boxes and the yielded Fm was divided 
by the calculated Fc. At least 5 axonal mitochondria were selected from individual 





2.8 Western Blotting 
 
10 larvae or 20 adult fly heads were collected for each sample preparation. Collected 
samples were homogenized and lysed in 200  l of lysis buffer containing 75 mM NaCl, 
2.5 mM MgCl2, 50 mM NaF, 0.1 mM EDTA, 0.5% Triton X-100 with protease inhibitor. 
Total proteins which were quantified by BCA protein assay kit (Pierce, #23227) were 
denatured by boiling with 40  l of 6X sample buffer containing 6% SDS, 30% glycerin, 
320 mM Tris-HCl and 3% -mercaptoethanol for 10 minutes at 95oC. Denatured samples 
were collected in 1.5 ml microfuge tubes, and supernatants were collected by 
centrifugation at 6,000 rpm for 10 minutes. Equal amount of proteins (30 - 60  g) were 
loaded on precast gels with protein standard (Bio-Rad, #161-0973), and separated by 
SDS-electrophoresis. Gels were run at 200V for 30 minutes. After protein separation, 
proteins in the SDS gels were transferred onto nitrocellulose membranes at 350 mA for 
90 minutes. Transferred membranes were cut for the different antibodies, and incubated 
in blocking solution (5% BSA in PBS) for 1 hour at room temperature with gentle 
shaking. After blocking, prepared primary antibodies were added into blocking solution, 
and the membranes in primary antibodies were incubated at 4oC for overnight with gentle 
shaking. Membranes were washed three times with 0.1% PBST for 10 minutes, then 
secondary antibodies in blocking solution were prepared in the dark. Treated membranes 
were additionally incubated at room temperature in darkness for 1 hour and washed three 
times with 0.1% PBST for 10 minutes. Proteins were quantified and visualized by 
Odyssey detection. The antibodies used in this study were as follows: rabbit anti-parkin 
(74N and 278N 213.03) at 1:1,000 and mouse anti-actin at 1:5,000 for the primary 
antibodies, and goat anti-rabbit Alexa 680 (Invitrogen, #1073054) at 1:5,000 and goat 










For immunostaining of neuromuscular junctions, late third instar larvae were partially 
dissected (2.2.1) and fixed with 4% paraformaldehyde in 3 concavities glass slide for 20 
minutes at room temperature (Shidara and Hollenbeck, 2010). Fixed samples were 
transferred to a 1.5 ml microfuge tubes, then washed twice with PBT (PBS containing 0.1% 
Triton X-100) for 15 minutes. Washed samples were blocked with PBTB (PBT 
containing 0.2% BSA) for 30 minutes, then stained with mouse anti-HRP (1:1000) that 
conjugated with Alexa594 goat anti-mouse (J.C. Clemens, Purdue University) for 
overnight at 4oC. After incubation, immunostained samples were rinsed twice with PBTB 
for 30 minutes before mounting and observation. Images of immunostained 





2.10 Statistical Analysis 
 
To analyze data from park25 mutants compared to controls, p-values were calculated 
using an unpaired homoscedastic t-test. For multiple group comparisons, statistical 
significance was calculated by one-way ANOVA with Bonferroni correction post test. 
Significance between two populations was determined by two-sample Kolmogorov-
Smirnov (K-S) test for analyzing the critical distribution. Correlations between two 
parameters were assessed by Pearson s correlation coefficient by R2 values. In all cases, 
at least three independent experiments were performed. Number of experimental samples, 
mitochondria, axons, cell bodies, synaptic boutons, larvae and cells, were indicated in 
figures and figure legends. Error bars represent means ± SEM. All statistical significance 




CHAPTER 3. RESULTS 
 
 
3.1 park25 Animals Display Loss of Parkin Expression 
 
In order to elucidate the role of Parkin in mitochondrial quality control, I first generated 
park25 null mutants for comparison with control animals. Wild type flies expressing a 
single copy of mitochondrially-targeted GFP (mito-GFP) driven by the D42 driver 
(Pilling et al., 2006) were used for the control (Table 2.1, #3), while park25 null mutants 
(Table 2.1, #6) were derived from crossing of park25, D42-Gal4/TM6B (III) and park25, 
UAS-mitoGFP/TM6B (III) (Greene et al., 2003). To confirm the deletion of park25 alleles 
(Figure 3.1, A), the protein expression was identified by western blot analysis. Here, the 
lysates were prepared from third instar larvae and adult heads respectively, and two 
antibodies (74N and 278N 213.03) were used for the Parkin detection. As expected, 
Parkin was not detected in park25 animals; though Parkin was not properly detected by 
74N, the protein expression was faintly detected from either lysate of control animals by 
278N 213.03 (Figure 3.1, B). This result confirms that park25 flies expressing mito-GFP 
in motor neurons described in this study are null alleles, and suggests that park25 flies will 





3.2 Loss of Parkin Alters Mitochondrial Axonal Traffic 
 
Currently, the cell body is predicted and proposed to be the major place where neuronal 
mitochondria are synthesized and degraded (Saxton and Hollenbeck, 2012). The 
PINK1/Parkin pathway has been proposed both to support mitochondrial quality control 
and turnover (Narendra et al., 2008; Matsuda et al., 2010; Narendra et al., 2010), and to 
regulate mitochondrial motility (Wang et al., 2011; Liu et al., 2012; Saxton and 
Hollenbeck, 2012). These two functions are likely to be related, as the return of senescent 
mitochondria to the cell body would require targeted net retrograde traffic. Thus, this 
current model raises the question of whether Parkin supports the axonal transport of 
senescent mitochondria for normal mitochondrial turnover processes. 
 
 
3.2.1 park25 animals display reduced organelle flux 
One strong expectation of current models is that Parkin deficiency will inhibit the 
turnover and retrograde traffic of mitochondria, causing an accumulation of senescent 
organelles in the axon. To test this hypothesis in vivo, I quantified the axonal transport of 
mitochondria in motor neurons of the intact Drosophila larval nervous system (Pilling et 
al., 2006; Russo et al., 2009). Using mitochondrially-targeted GFP (mito-GFP) driven by 
D42, transport was quantified in both directions in the proximal (segment A2), middle 
(A4) and distal (A7) regions of the segmental nerves (SNs), and was compared between 
control (wild type with D42-Gal4>UAS-mitoGFP) and park25 (parkin null) animals 
(Figure 3.2, A) (Devireddy et al., 2014). Consistent with previous analysis, mitochondrial 
flux in control motor axons was greater in the anterograde than retrograde direction, and 
declined with distance from the cell body in SNs (Shidara and Hollenbeck, 2010). In 
park25 SNs, flux was attenuated in both directions (Figure 3.2, B). Specifically, 
anterograde fluxes were more severely impaired than retrograde fluxes in park25 SNs; 
anterograde fluxes dropped to 48% (A2), 41% (A4) and 53% (A7) of control while 
retrograde fluxes dropped to 70% (A2), 53% (A4) and 61% (A7). In order to confirm that 
the reduced fluxes in park25 SNs were specifically affected by parkin perturbation, I 
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genetically over-expressed Parkin in null mutant lines by UAS-Parkin. Reduced fluxes in 
A4 SN of park25 were significantly rescued by Parkin over-expression, in both directions 
(Figure 3.2, B and C). 
 
 
3.2.2 park25 animals display normal features of mitochondrial movements 
Because this pathway has been proposed to specifically detach kinesin from the 
mitochondrial surface (Wang et al., 2011), we next examined whether reduced 
mitochondrial flux in park25 SNs derived from alteration of particular elements of 
mitochondrial motility. We analyzed the mitochondrial velocities, % moving, duty cycle 
and run length (Devireddy et al., 2014). In park25 SNs, mitochondrial velocities in both 
directions were similar to those of controls throughout the axons (Figure 3.3, A), and the 
percentages of moving and stationary mitochondria in motor axons were unaffected by 
Parkin deletion (Figure 3.3, B). This eliminated the major movement parameters as 
sources of the flux deficit, but we further measured the duty cycle and run length of 
moving mitochondria, and found that park25 mutants showed a modestly increased % of 
their time pausing during mitochondrial movement in both directions (Figure 3.3, C) 
caused by reduced proportion of movements in the dominant direction. However, the run 
lengths of moving mitochondria were similar, with only a small deficit in the A4 region 
of SNs (Figure 3.3, D). These data indicate that although the loss of Parkin significantly 
reduces mitochondrial flux in the axon, mitochondrial motility behaviors and the % of 






Figure 3.3 Parkin mutants show only modestly altered duty cycle and run length. (A), 
Mitochondrial net velocity in different parkin genotypes. park25 mutants retain normal 
mitochondrial velocities in both directions throughout the SNs. (n/n) = number of 
mitochondria/number of animals. (B), The percentages of moving and stationary 
mitochondria are unaffected in park25 SNs. (n) = number of animals. (C), Mitochondrial 
duty cycle in axons in different parkin genotypes. park25 mutants showed a modest 
increase in % of time pausing during mitochondrial movement in both directions. (n) = 
number of mitochondria. (D), Mitochondrial run lengths. park25 mutants showed a 
modest decrease in retrograde run length, only in the A4 region of SNs. (n/n) = number of 
mitochondria/number of animals. Mitochondrial duty cycles and run lengths were 
measured from moving mitochondria in axons in A2, A4 and A7 SNs. Error bars indicate 














3.3 Loss of Parkin Produces Reduced Axonal Mitochondrial Density 
 
If mitochondrial motility was essentially normal in park25 mutant animals, what could 
explain the large decrease in flux? One possibility is that Parkin deficiency reduces the 
number of mitochondria in the axon. This would run contrary to expectations, since the 
proposed role of the PINK1/Parkin pathway in mitochondrial turnover predicts that 
Parkin deficiency would cause the accumulation of senescent mitochondria (Narendra et 
al., 2008; Matsuda et al., 2010; Narendra et al., 2010). Nonetheless, I assessed this 
possibility by quantifying total mitochondrial density (both moving and stationary) in 
larval segmental nerves, motor synaptic boutons and axons from adult fly wing.  
 
 
3.3.1 park25 animals display reduced axonal mitochondrial density in larval segmental 
nerves 
I first considered organelle density in motor axons to verify the cause of reduced 
mitochondrial fluxes (Devireddy et al., 2014). There was clear and pronounced loss of 
axonal mitochondria throughout park25 motor axons: mitochondrial density within 50  m 
axonal length was reduced to 51.70% (A2), 60.93% (A4) and 55.58% (A7) of control in 
park25 segmental nerves (Figure 3.4, A and B). This deficit was restored in A4 of park25 
segmental nerves by Parkin over-expression (Figure 3.4, A and C). Though it was 
unexpected because of the proposed role of Parkin for targeting dysfunctional 
mitochondria (Narendra et al., 2008; Matsuda et al., 2010; Narendra et al., 2010), these 
results raise a possible idea to elucidate the cause of reduced mitochondrial fluxes that I 
found in park25 segmental nerves (Figure 3.2, B): that the altered mitochondrial flux in 
park25 motor axons results mainly from reduced organelle density. 
 
 




Since park25 segmental nerves displayed reduced axonal mitochondrial density, I further 
monitored their neuromuscular junctions to verify whether there is any accumulation of 
mitochondria in park25 motor synaptic boutons. To quantify the density of mitochondria 
from motor synaptic boutons, neuromuscular junctions were stained with anti-HRP and 
selected between muscles 7 (M7) and 6 (M6) from the middle (A4) of the body wall. As 
in park25 segmental nerves, a reduced mitochondrial density is observed in synaptic 
boutons of park25 mutants (Figure 3.5, A and B). Together with Figure 3.4, these results 
suggest that park25 animals do not accumulate senescent mitochondria neither in 
segmental nerves nor in motor synaptic boutons.  
 
 
3.3.3 park25 animals display reduced axonal mitochondrial density in adult fly wings 
As described above, contrary to expectations, park25 animals do not accumulate senescent 
mitochondria either in segmental nerves or in motor synaptic boutons; rather, they 
display reduced axonal mitochondrial density. To confirm this deficit in park25 adult 
animals, I examined mitochondria in the wing, where a subset of sensory neurons express 
genes driven by D42 driver, and these are situated along the wing margin (L0 vein and 
L1 vein) with L3 vein (Fang et al., 2012). I visualized D42>mito-GFP mitochondria in 
these sensory axons by observing the humeral crossvein (HCV) of LV1 (Figure 3.6, A 
and B). As in the larval nervous system, HCV axons of park25 mutant wings showed 
reduced mitochondrial density (Figure 3.6, C). However, unlike the larval segmental 
nerves, the deficit was not significantly restored by Parkin over-expression. Perhaps, 
Parkin expression may differ in developmental stage and/or after the animal 
metamorphosis. Collectively, this result consistently indicates that park25 animals also 
contain fewer axonal mitochondria and suggests that park25 animals display this reduced 








3.4 Parkin Perturbation Produces Reduced Number of Motile Mitochondria 
 
3.4.1 park25 animals display reduced number of steady-state moving mitochondria 
The majority of mitochondria in axons are persistently stationary: 73.8 ± 0.82% (A2), 
74.3 ± 1.46% (A4) and 82.9 ± 1.47% (A7) of axonal mitochondria were stationary in 
control animals, while 75.9 ± 1.94% (A2), 75.8 ± 1.32% (A4) and 80.8 ± 2.18% (A7) of 
axonal mitochondria were stationary in park25 animals (Figure 3.3, B). So next I 
separately assessed the density of moving mitochondria from larval motor axons to 
further analyze the relationship between axonal mitochondrial flux and density. Here, I 
monitored the number of steady state moving mitochondria over a time course from 30 
 m photobleached axonal regions (Figure 3.7, A). By counting mitochondrial entry into 
bleached regions, I found a reduced steady state density of moving mitochondria in 
park25 axons and this reduction was partially rescued by Parkin over-expression (Figure 
3.7, B). However, equal times were required to fill a bleached region to the steady state 
density of moving mitochondria: both control and park25 animals required ~ 210 seconds 
to reach plateau phase (Figure 3.7, B). Again, this suggests that reduced mitochondrial 
fluxes in park25 axons are mainly caused by reduced mitochondrial density rather than 
altered mitochondrial velocities.  
To quantify the reduced mitochondrial density further in bleached regions, I also 
estimated the number of moving mitochondria from double reciprocal plots (Figure 3.7, 
C). 30 and 29 steady state moving mitochondria were estimated in control and park25, 
Parkin animals respectively, while 17 steady state moving mitochondria were estimated 
in park25 mutants from the 30  m photobleached regions: control from (y = 0.033e63.612x), 
park25 from (y = 0.059e58.643x) and park25, Parkin from (y = 0.035e63.741x). Thus, these 
data reconfirm that park25 segmental nerves contain less moving mitochondria, and reveal 
that the unexpected results of attenuated fluxes in park25 axons are mainly caused by a 





3.4.2 Estimated numbers of steady-state moving mitochondria are consistent with 
numbers calculated from % of movement 
Since I quantified the percentage of moving mitochondria by monitoring total amount of 
organelles (moving and stationary) from A4 segmental nerves (Figure 3.3, B), I tried to 
reconfirm the estimated number of steady state moving mitochondria by comparing with 
the numbers calculated with the % of movement. From A4 segmental nerves, the average 
number of total mitochondria within the assigned length (51.2   ) was 180 in control, 
while 110 in park25. And the mean % of moving mitochondria was 25.71% in control, 
while 24.21% in park25. Since I photo-bleached 30   in the middle of segmental nerves, 
the calculated number of steady state moving mitochondria from control was 27.12 (180 
× 30 / 50.2 × 0.2571) and from park25 was 15.60 (110 × 30 / 51.2 × 0.2421). As these 
numbers are close to 30 and 17 respectively, it reconfirms that park25 segmental nerves 
contain fewer moving mitochondria and consistently suggests that reduced mitochondrial 
axonal density produced by parkin deletion causes most of the reduction in mitochondrial 




3.5 Loss of Parkin Display Normal Status of Axonal Mitochondria 
 
The Parkin pathway has also been proposed to keep senescent, depolarized mitochondria 
from fusing with normal ones by promoting the degradation of Mitofusin (Deng et al., 
2008; Poole et al., 2010; Ziviani et al., 2010). Thus, another prediction of current models 





3.5.1 park25 animals retain normal morphology of mitochondria in axons 
As a reduced density of mitochondria was found in park25 motor axons, I further asked 
whether those remaining axonal mitochondria have normal or compromised 
mitochondrial morphology. I first measured the length of both stationary and moving 
axonal mitochondria in controls, and found that the mean length of moving mitochondria 
was 0.8 times that of stationary ones in general. Surprisingly, the mean length of either 
stationary or moving mitochondria from segmental nerves was not affected by parkin 
perturbation (Figure 3.8, A). Mean length of stationary mitochondria was 1.54 ± 0.01 m 
in control and 1.55 ± 0.01 m in park25, while mean length of moving mitochondria was 
1.38 ± 0.03 m in control and 1.28 ± 0.03 m in park25. To elucidate whether a length 
difference in park25 mutants might be manifested not in the population average, but as a 
small outlying population of longer mitochondria, I also examined the length distribution 
by a two-sample Kolmogorov-Smirnov test (Figure 3.8, B). However, there was no 
significant difference between control and park25 mutants, for either moving or stationary 
mitochondria: K-S statistics from each of stationary and moving mitochondrial length 
were smaller than critical distribution. Thus, these data indicate that axonal mitochondrial 
length is not affected by parkin perturbation which contradicts the idea that Parkin 
controls fission-fusion steady state. 
 Next, I further measured the projected area of axonal mitochondria to confirm 
whether park25 mutants show any shape differences in axonal mitochondria. However, 
area of mitochondria in park25 SNs was comparable to control throughout the axons 
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(Figure 3.9, A and B): 0.82 ± 0.01  m2 with 0.56  m mean height in control and 0.79 ± 
0.01  m2 with 0.56  m mean height in park25. Collectively, these in vivo data from 
morphological analysis indicate that Parkin seems to be dispensable for maintaining 
normal mitochondrial morphology in motor axons.  
 
 
3.5.2 park25 animals retain normal inner membrane potential of mitochondria in axons 
To test whether the remaining axonal mitochondria in park25 mutants nonetheless display 
normal membrane potential, I assessed the m of mitochondria from intact larval motor 
neurons. Tetramethylrhodamine methyl ester (TMRM) was used for determination of 
mitochondrial transmembrane potential. Since the fluorescent probe of TMRM does not 
successfully penetrate into the larval segmental nerves due to their connective tissue sheet 
(Figure 3.10, A), axonal mitochondria within axons of thin nerves adjacent to the larval 
A4 segment were selected for in vivo quantification (Verburg and Hollenbeck, 2008; 
Shidara and Hollenbeck, 2010; Devireddy et al., 2014; Devireddy et al., 2015). The 
acquired TMRM images were thresholded at an intensity of 400 to identify pixels 
belonging to mitochondria and to determine the mitochondrial fluorescence intensities 
(Fm), while the mean intensity of two area boxes (7 by 7 pixels) adjacent to the assigned 
mitochondria was used to determine the cytoplasmic fluorescence intensities (Fc). The 
ratio of mitochondrial to cytoplasmic fluorescence intensities (Fm/Fc) was used as a 
logarithmic quantification of mitochondrial inner membrane potential (m) (Verburg 
and Hollenbeck, 2008; Shidara and Hollenbeck, 2010). Surprisingly, mitochondrial m 
was properly maintained in thin axons of park25 SNs (Figure 3.10, B and C), and the 
reduced axonal mitochondrial density observed in segmental nerves was also apparent in 
these thin nerves (Figure 3.10, B). 
 
 




The in vivo data from larval motor neurons indicate that there is lack of the predicted 
accumulation of senescent mitochondria in park25 mutant axons. Instead, I found a 
reduced number of mitochondria not only from mutant axons (Figure 3.4) but also from 
mutant neuromuscular junctions (Figure 3.5). This raises an additional question whether 
those remaining mitochondria in park25 mutant synaptic terminal also retain normal 
metabolic state. To verify this issue, I assessed the  m of mitochondria from larval 
neuromuscular junctions of A4 segments, and found that the remaining mitochondria in 
park25 synaptic boutons display preserved a normal inner membrane potential (Figure 
3.11, A and B). I also quantified the distribution of TMRM intensity to understand 
whether a difference of mitochondrial  m in park
25 mutants might be manifested not in 
the population average, but as a small outlying population of diminished  m of 
mitochondria, and found a comparable distribution of TMRM intensity between control 
and park25: K-S statistics show no significant difference between two groups (Figure 3.11, 
C). Collectively, these results thus suggest that Parkin perturbation fails to produce the 
predicted accumulation of enlarged, longer and senescent mitochondria both in motor 
axons and in synaptic terminal in vivo; park25 mutant animals display normal status for 

















3.6 Correlation between Axonal Mitochondrial Length and Velocity 
 
Having already measured net velocities of moving mitochondria for quantifying axonal 
transport, I then regressed mitochondrial velocities against their lengths to understand any 
relationship between transport and morphology. Although lengths were distributed from 
0.35  m to 4.65  m, the net velocities of mitochondria were consistent in both directions. 
There was no correlation between mitochondrial length and velocity or direction of 
movement (Figure 3.12). Determination of correlation coefficient (R2) from each groups 
verified no difference: anterograde mitochondria from control (R2 = 0.0097), retrograde 
mitochondria from control (R2 = 0.0059) and anterograde mitochondria from park25 (R2 = 
0.0155), retrograde mitochondria from park25 (R2 = 0.031). Though this seems 
counterintuitive on its face, it is consistent with previous studies that have shown no 
effect of mitochondrial length on axonal motility except at extreme, non-physiological 









Figure 3.12 Relationship between axonal mitochondrial velocity and length in motor 
neurons. Individual moving mitochondria in larval motor axons are plotted by their 
length and velocity. Correlation coefficients are verified by R2 values: no correlation 
between two variables, R2 values   0.65 (anterograde mitochondria from control (R2 = 
0.0097), retrograde mitochondria from control (R2 = 0.0059) and anterograde 
mitochondria from park25 (R2 = 0.0155), retrograde mitochondria from park25 (R2 = 














3.7 Parkin Deficit Produces Abnormal Mitochondrial Morphology in Motor Cell Bodies 
 
The observed defects - a reduced number of mitochondria with normal organelle status - 
in park25 axons contradicted the predicted expectation that senescent mitochondria would 
accumulated due to parkin perturbation. This raised the possibility that the cell body itself 
is the main locus of Parkin-dependent turnover and/or Parkin-dependent mitochondrial 
biogenesis, perhaps including regulation of mitochondrial entrance into the axon. Thus, I 
further analyzed the morphology of mitochondria in motor cell bodies of the larval 
nervous system. Interestingly, abnormal morphologies, tubular and reticular, of 
mitochondria were found in park25 motor cell bodies (Figure 3.13, A). To quantify these 
complex differences in organelle morphology, I categorized the mitochondria into four 
different types by their morphological appearances - fragmented (1), wild type (2), 
tubular (3) and hyper-fused (4) - and scored them while blinded to the genotype. 
Interestingly, a higher frequency of tubular and hyper-fused mitochondria was formed in 
park25 motor cell bodies: 7.5 % of tubular (3) and 0.0 % of hyper-fused (4) were formed 
in controls, while 54.2 % of tubular (3) and 26.4 % of hyper-fused (4) were formed in 
park25 (Figure 3.13, B). To further confirm the role of Parkin in mitochondrial 
morphology in motor cell bodies, I over-expressed Parkin by UAS-Parkin and the 
morphological deficit was partially restored (Figure 3.13, A and B). Therefore, these data 
demonstrate that in contrast to motor axons (Figure 3.8 and 3.9), in cell bodies Parkin is 
essential for the maintenance of normal mitochondrial morphology. Along with the data 
from Figure 3.7, these results also indicate the importance of Parkin in mitochondrial 
interconnected network within neuron that Parkin is critical for both normal 
mitochondrial morphology in the cell body and their entry into the axon, and suggest a 
likely relation of the two: that normal somatic organelle morphology, reflecting a normal 





3.8 Parkin-dependent Mitophagy Is Undetectable in Motor Neurons In Vivo 
 
Studies in embryonic neurons in vitro have shown that autophagosomes arise in the distal 
axon and undergo maturation during their retrograde transport (Maday et al., 2012; 
Maday and Holzbaur, 2014). Since the PINK1/Parkin pathway is thought to be necessary 
for local mitophagy in the distal axon (Ashrafi et al., 2014), the lack of evidence for 
Parkin-dependent axonal mitochondrial turnover that I found here was surprising and 
raised the question of whether Parkin is actually responsible for local mitophagy 
processes in vivo. To understand further the role of Parkin in neuronal mitophagy, I 
visualized simultaneously mitochondria and autophagic vacuoles in Drosophila larval 
motor neurons (Figure 3.14): mitochondria were visualized by mito-GFP, while 




3.8.1 No detectable co-localization of mitochondria with autophagic vacuoles in motor 
cell bodies in vivo 
As I already observed the altered morphology of mitochondria in the cell bodies, I first 
tried to quantify the co-localization of autophagosomes with mitochondria from the 
motor cell bodies to examine whether Parkin plays a critical role in targeting 
dysfunctional mitochondria. Consistent with my previous data (Figure 3.13), tubular and 
elongated mitochondria were found in park25 cell bodies. However, mitochondria almost 
completely failed to co-localize with autophagic vacuoles in either control or park25 cell 
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represent discrete organelle particles. Since autophagic vacuoles barely co-localized with 
mitochondria even under basal conditions, I prevented larvae from feeding for 6 hours 
before observation to trigger starvation-induced autophagy (Gomes et al., 2011; Rambold 
et al., 2011; Ghosh et al., 2012). Though this treatment caused the expected 
mitochondrial fragmentation (Gomes et al., 2011; Rambold et al., 2011), which should 
render mitochondria even better candidates for engulfment, the co-localization of 
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autophagic vacuoles with mitochondria was still not detected from either control or 
park25    	
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hypothesis that Parkin deficiency would reduce the rate of mitophagy in vivo, because 
there was no detectable mitophagy even in controls under either normal physiological or 
starvation-induced autophagic conditions.  
 
 
3.8.2 No detectable co-localization of mitochondria with autophagic vacuoles in motor 
axons in vivo 
Although there was no detectable co-localization of autophagosomes with mitochondria 
in motor cell bodies from our in vivo larval system, it remained possible that 
mitophagosomes arose in the distal axon and completed degradation during retrograde 
transport, making autophagosome-mitochondria co-localization undetected in cell bodies. 
Thus, I monitored autophagic vacuoles along the axon to elucidate whether the 
mitophagy process can occur during the autophagic maturation. However, in axons, as in 
cell bodies I observed a striking lack of co-localization of autophagic vacuoles with 
mitochondria in either control or park25 animals (Figure 3.16, A - D). Thus, these results 
indicate that the mitophagy process is essentially absent in vivo at least in the form of 
mitochondrial engulfment by autophagosomes. 
 As expected from previous studies (Maday et al., 2012), axonal autophagic 
vacuoles mainly moved retrogradely and rarely changed their direction, while 
mitochondria showed pauses and/or salutatory, bidirectional movements (Figure 3.17, A). 
In general, the majority of retrograde moving autophagic vacuoles displayed faster 
movement than those of moving mitochondria. To understand whether Parkin is involved 
in organelle axonal transport, I simultaneously analyzed axonal movements of 
mitochondria and autophagic vacuoles by flux measurement. Consistent with the 
previous data (Figure 3.2), mitochondrial flux was greater in the anterograde than 
retrograde direction, and the fluxes were reduced by parkin perturbation in both 
directions (Figure 3.17, B). Unlike mitochondria, autophagosomes displayed a higher 
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flux in the retrograde direction than in anterograde. Interestingly, autophagic vacuole flux 
was also substantially reduced in park25 mutants, but specifically in the retrograde 
direction (Figure 3.17, C): park25 mutants showed anterograde AV flux equal to that of 
control, while retrograde flux was reduced by 50%. Collectively, these results indicate 
that while autophagic vacuoles are apparent and their axonal transport is consistent with 
them having a Parkin-dependent origin and/or maturation in the distal axon, mitophagy is 




















3.9 Parkin-dependent Mitophagy Is Detectable in Drosophila Neurons In Vitro 
 
It is notable that the most of the previous studies that have supported a role for Parkin in 
mitochondrial turnover and mitophagy were done in vitro, with either neuronal (Ashrafi 
et al., 2014) or non-neuronal (Narendra et al., 2008; Matsuda et al., 2010; Narendra et al., 
2010; Lazarou et al., 2015) cells. As described above, however, mitochondria did not co-
localized with autophagic vacuoles and there was no successful engulfment of 
mitochondria by autophagosomes in our Drosophila larval in vivo system. Thus, I next 
sought to examine whether mitophagy events can be detected in neurons in vitro in the 
same system that I used for the in vivo studies. Here, I used a Drosophila primary 
neuronal culture system to further investigate the role of Parkin in mitophagy process. 
 
 
3.9.1 park25 neurons display inhibited mitochondrial engulfment into autophagosomes in 
vitro 
To investigate the role of Parkin in mitophagy process in vitro, I grew Drosophila 
primary motor neurons in culture, using the mito-GFP larvae as the source of cells (Bai et 
al., 2009; Pathak et al., 2010). Cells were plated into tissue culture dishes, and incubated 
for 96 hours to allow neurons to extend their processes. Mitochondria and autophagic 
vacuoles which visualized by mito-GFP and RFP-atg8 respectively were monitored in 
motor cell bodies and projected axons to analyze the mitophagy process in vitro. 
Surprisingly, unlike the in vivo data, I observed numerous autophagic vacuoles that co-
localized with mitochondria in vitro. Not only did control neurons show this evidence for 
mitophagy in vitro, but the frequency of autophagosome-mitochondrial co-localization 
was substantially reduced in neurons from park25 mutant larvae: frequencies were 
reduced to 33% of control levels in the cell bodies and 27% in the axons (Figure 3.18, A 
and B). Interestingly, however, number of the autophagic vacuoles of all kinds per cell in 
neurons cultured from park25 mutants was not reduced relative to controls in either the 
cell bodies or axonal regions (Figure 3.18, C). These results suggest that in vitro Parkin 
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plays an essential role in mitochondrial engulfment by autophagosomes, and also indicate 
that Parkin does not control the general process of autophagy.  
 
 
3.9.2 park25 neurons display elongated axonal mitochondria in vitro 
Unlike in vivo, another distinct feature of mitochondria from in vitro neurons was that I 
could observe more elongated axonal mitochondria in park25 mutant cells (Figure 3.19, 
A), which is predicted by current models of the role of Parkin in mitochondrial 
morphology (Deng et al., 2008). The mean length of axonal mitochondria was 2.48 ± 
0.12  m in control neurons, while mean length of axonal mitochondria was 4.10 ± 0.46 
 m in park25 cells. 
In the neuronal (Ashrafi et al., 2014) as well as non-neuronal (Matsuda et al., 
2010; Narendra et al., 2010) environments, mitochondria that undergo mitophagy mostly 
show an isolated status and fragmented morphology. As expected, the mitochondria 
engulfed by autophagic vacuoles that I observed from cultured neurons were smaller than 
others, and fragmented (Figure 3.18, A). Thus, I further asked whether the size of 
mitochondria, rather than Parkin expressions is critical for the mitophagy event as 
visualized by autophagosome-mitochondria co-localization. To remodel mitochondria 
independently of Parkin perturbation, neurons were treated with 5  M of Antimycin A 
(Ant A), an inhibitor of respiratory complex III that depolarizes neuronal mitochondria 
(Slater, 1973; Cai et al., 2012). Applying 5  M of Ant A for 20 minutes caused a 
significant decrease in mitochondrial length in park25 cells (Figure 3.19, A), but they still 
contained a comparable number of autophagic vacuoles in both cell bodies and axons 
(Figure 3.18, C). However, mitochondrial engulfment via autophagosomes was still 
inhibited in park25 mutant neurons: the frequencies of autophagic vacuoles with 
fragmented mitochondria from park25 mutants were reduced to 28% of control levels in 
cell bodies and 49% in axons (Figure 3.18, A and B). 
 To further understand whether autophagic induction by itself can modulate 
autophagosome-mitochondria co-localization regardless of Parkin, I also tested the role 
of Parkin in mitophagy under conditions of experimental autophagic induction. To 
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promote mitophagy, cells were treated with 100  M of H2O2, a reactive oxygen species 
that induces autophagic process through oxidative stress (Court and Coleman, 2012). 
Again, mitochondrial size was significantly decreased in both control and park25 cells by 
H2O2 treatment for 1 hour (Figure 3.19, A). However, even under conditions of oxidative 
stress I observed inhibition of mitochondrial engulfment in park25 mutant cells: in H2O2-
treated cells the frequency of autophagic vacuoles co-localizing with mitochondria was 
reduced to 18% of control levels in cell bodies and to 39% in axons (Figure 3.18, A and 
B). Collectively, these data suggest that that Parkin regulates mitophagy in vitro 
independently of the modulation of mitochondrial size. Furthermore, since both Ant A 
and H2O2 treatments cause fragmentation of mitochondria (Figure 3.19, B) but no 
increase in autophagic vacuoles (Figure 3.18, C), I also can conclude that Parkin is 
dispensable for the remodeling of damaged mitochondria and for the regulation of 
general autophagy in vitro. 
 
 
3.9.3 park25 neurons display diminished inner membrane potential of axonal 
mitochondria in vitro 
Since I saw elongated axonal mitochondria and inhibited autophagosomal engulfment in 
park25 neurons in vitro, I further asked whether those axonal mitochondria in park25 cells 
preserve the normal inner membrane potential. Mitochondrial m was determined by 
using the intensity ratio of TMRM staining between mitochondria and cytosol within the 
projected axons. Intriguingly, park25 cells displayed diminished m in neuronal axons 
(Figure 3.20, A and B). Consistent with previous analysis, axonal mitochondria were 
elongated in park25 cells (Figure 3. 20, C). For this reason, I additionally regressed 
mitochondrial m against their lengths to determine whether neurons in vitro display a 
key predicted consequence of Parkin-mediated mitochondrial quality control: the 
accumulation of longer, less polarized organelles in the absence of Parkin. I found that 
indeed, park25 motor axons contained a small outlying population of longer mitochondria, 
and those mitochondria generally displayed diminished m (Figure 3.20, D and E): the 
length distribution by a two-sample Kolmogorov-Smirnov test shows a significant 
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difference between the two groups (D = 0.2107 > critical D = 0.1274 with a 
corresponding p < 0.001). Thus, as previously reported, I also find a significant in vitro 
role for Parkin in regulating axonal mitochondrial morphology and metabolic state; 














Figure 3.18 Parkin is essential for mitochondrial engulfment by autophagosomes in 
vitro. (A), Images of in vitro primary motor neurons expressing mito-GFP and RFP-Atg8 
after 96 hours in culture.  For stress conditions, cells are exposed to Antimycin A (Ant A; 
    	
  2O2    
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the co-localization of mi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!    n) = number of cells. 
(B), Frequency of autophagosomes that contain mitochondria under each condition. 
Mitochondrial engulfment into AVs is inhibited in park25 mutant neurons. (C), Number 
of AVs per cell under each condition within cell bodies or axons. Error bars indicate 
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	 "  #  		  	 $  
	% t-test. *p < 0.05, **p < 0.01 and 




Figure 3.19 Elongated mitochondria are produced in park25 primary neurons in vitro. 
(A), Mean length of axonal mitochondria in different parkin genotypes in exposed 
conditions respectively. park25 mutant neurons show elongated axonal mitochondria. 
Axonal mitochondrial elongation in park25 neurons is inhibited by either treatment (Ant 
A or H2O2). (n/n) = number of mitochondria/number of cells. Error bars indicate mean ± 
SEM. Significance is determined by one-way ANOVA with Bonferroni correction (*p < 
0.05, **p < 0.01 and ***p < 0.001). (B), Length distribution of axonal mitochondria in 
different parkin genotypes. Ant A or H2O2 treatment caused axonal mitochondrial 
fragmentation in both control and park25 mutant neurons in vitro. Data were assessed by a 
two-sample Kolmogorov-Smirnov test (mitochondrial fragmentation caused by Ant A or 
H2O2 treatments was significantly different from basal for both control and park
25 
animals: D = 0.22 > critical D = 0.20 for Ant A and D = 0.47 > critical D = 0.19 for 
H2O2 in control, D = 0.40 > critical D = 0.27 for Ant A and D = 0.42 > critical D = 0.29 





3.10 Generation of park1 Mutant Fly Expressing mito-GFP in Motor Neurons 
 
As described above, park25 mutant animals displayed dramatic defects of mitochondrial 
dynamics and morphology in larval motor neurons in vivo, and that were: 1) attenuated 
mitochondrial fluxes in axons (Figure 3.2); 2) reduced mitochondrial density in axons 
(Figure 3.4); 3) morphological defects of mitochondria in cell bodies (Figure 3.13). Since 
those defects were generally restored by UAS-Parkin expression; one exception was 
reduced mitochondrial axonal density from adult fly wing (Figure 3.6), I tried to further 
confirm the in vivo role of Parkin in mitochondrial dynamics and morphology by using 
another null mutant, park1 allele (J.C. Clemens, Purdue University). Genomic structure of 
Drosophila parkin contains 7 exons, and park1 null allele was generated by P-element 
insertion within the fifth exon (Cha et al., 2005) (Figure 3.21). I built park1 mutant 
animals that contains D42>mito-GFP transgene by genetic recombination because of the 
park1 locus in fly chromosomes; both D42-Gal4>UAS-mitoGFP (Table 2.1, #1) and 
park1 (Table 2.1, #19) localize within chromosome (III).  
 
 
3.10.1 Genetic recombination 
To build park1 mutant animals that contain D42>mito-GFP transgene, first I collected 
virgin females of D42-Gal4>UAS-mitoGFP (III) and crossed them with males of 
park1/TM6B (III) to get the heterozygous animals of D42-Gal4>UAS-mitoGFP/park1 
(III). Then virgin females from the generated heterozygous animals of D42-Gal4>UAS-
mitoGFP/park1 (III) was crossed again with males that harbor double balancer of 
TM2/TM6B (III) (Table 2.1, #20). This crossbreeding basically produced four genotypes 
of progenies: D42-Gal4>UAS-mitoGFP/TM2 (III), D42-Gal4>UAS-mitoGFP/TM6B 
(III), park1/TM2 (III) or park1/TM6B (III), however, I could expect to get heterozygous of 
park1 allele animals that contain D42-Gal4>UAS-mitoGFP by chromosomal 
recombination in this step. By this reason, I collected adult males that eclosed from the 
first filial generation: the flies were selected by tubby with red eye, and cross them with 
females of park1/TM6B (III) individually to confirm the genotype of male flies at the 
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second filial generation. 247 adult males were collected by two sets of crossbreeding (108 
from set 1 and 139 from set 2) from the first filial generation, and 5 among 247 were 
confirmed by thoracic indentation penetrance (Poole et al., 2008) at the third filial 
generation (Figure 3.22). To finally obtain the heterozygous of park1, D42-Gal4>UAS-
mitoGFP/TM6B (III) animals, flies expressing tubby with red eye phenotypes that 
already confirmed by thoracic indentation were isolated and maintained.  
 
 
3.10.2 park1, D42>mito-GFP animals display loss of Parkin expression 
The generated park1, D42-Gal4>UAS-mitoGFP/TM6B (III) transgenic animals were first 
confirmed and isolated by the Parkin null fly phenotype of thoracic indentation. However, 
the observed phenotypic penetrance of park1 homozygous flies was ~ 30%. Thus, I 
checked the protein expression by western blot analysis to confirm further the null nature 
of park1 alleles. Here, adult head extracts from the male flies were prepared for the 
lysates, and anti-Parkin antiboby (278N 213.03) and mouse anti- -tubulin were used for 
the Parkin and loading control detection respectively. Since the molecular weights of 
Parkin (~52 kDa) and  -tubulin (~50 kDa) were too close to identify on membrane 
separation, I washed the membrane with stripping buffer which contains -
mercaptoethanol to remove anti-Parkin antibody after the Parkin detection. Then, the 
membrane was used for  -tubulin detection. As expected, Parkin was not detected in 
park1 transgenic animals (Figure 3.23). Therefore, this result confirms that park1 flies 
expressing mito-GFP in motor neurons that I generated by genetic recombination are null 
alleles, and suggests that park1, D42-Gal4>UAS-mitoGFP flies will display the loss of 
Parkin function for further understanding the in vivo role of Parkin in mitochondrial 









CHAPTER 4. DISCUSSION 
 
 
Mitochondria play critical roles in cellular function, homeostasis and survival. Since 
mitochondria display a dynamic life cycle, their maintenance and long-term survival 
highly require adequate organelle QC. Because of their increased energy demand, post-
mitotic neurons are exemplary cell types that are more susceptible to defective 
mitochondrial QC. Therefore, mitochondrial quality should be well controlled to avoid 
neuronal defects as well as neuronal death. Many factors are likely to act to help maintain 
mitochondrial QC in neurons. First, axonal transport of mitochondria along the 
cytoskeleton is important for organelle distribution and turnover. This probably supports 
the traffic of dysfunctional mitochondria to a site of removal in neurons. Second, 
mitochondria can undergo a constant cycle of shape changes by fission-fusion that helps 
to accommodate the damaged components of the organelle. Thus, dysfunctional 
mitochondria can be segregated and isolated by preventing fusion, or the damaged 
material in the organelle can be diluted and exchanged by allowing fusion. Third, the 
dysfunctional mitochondria can be engulfed into autophagosomes to trigger their removal 
process through lysosomal digestion. In neurons, this mitophagy process may be 
regulated in a selective and/or non-selective manner. Because neurons are highly 
compartmentalized cells, with structurally and functionally distinct somatodendritic and 
axonal compartments, it is important to understand not just whether and how 
dysfunctional mitochondria are turned over, but also where this occurs.  
 In cells in vitro, the PINK1 and Parkin pathway has been proposed both to target 
dysfunctional mitochondria for turnover, and, in a related fashion, to regulate 
mitochondrial transport and fission-fusion dynamics. In this context, understanding the in 
vivo role of Parkin is important for better evaluating both mitochondrial dynamics 
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and their life cycle. In this study, I report important findings on Parkin-dependent 
mitochondrial QC from in vivo and in vitro Drosophila larval nervous systems: 1) Parkin 
deficient animals display a dramatically reduced amount of axonal mitochondria, while 
preserving     	
  	 	    m; 2) the 
mitochondrial in vivo fission-fusion balance is compartmentally regulated in the cell body 
in a Parkin-dependent manner; 3) unlike in vivo, the mitophagy process is prominent in 
cultured neurons, and requires Parkin.  
 
 
4.1 Role of Parkin in Mitochondrial Axonal Transport and Quality Control 
 
Studies of mitochondrial transport in neurons have been critical for a better understanding 
of how organelle turnover works in compartmentalized cells. In neurons, axonal transport 
of mitochondria has long been held to be intimately related to other organelle functions 
such as fission-fusion, metabolism and turnover (Miller and Sheetz, 2004; Baloh et al., 
2007; Pathak et al., 2010; Arduino et al., 2012; Saxton and Hollenbeck, 2012). A model 
for Parkin involvement in axonal mitochondrial motility is that PINK1/Parkin specifically 
dissociates kinesin, the MT-based anterograde motor, from the organelle surface through 
degradation of its linker protein, Miro (Wang et al., 2011). This proposed model, 
however, is inadequate to explain why and how the disruption of mitochondrial 
movement occurs in both directions, not only in anterograde also in retrograde, by PINK1 
and Parkin modulations. Since disruptions targeted to one direction of MT-based axonal 
transport often alter organelle movement in both directions (Pilling et al., 2006; Park et 
al., 2009; Russo et al., 2009), it is possible that the regulation of MT-based axonal 
transport is intricately coupled between the motors for the two directions of movement, 
kinesin and dynein. In any case, contrary to the proposed model of PINK1/Parkin 
dependent mitochondrial arrest, here I observed nearly unchanged mitochondrial motility 
behavior in vivo when the Parkin expression was perturbed (Figure 3.3). Instead, I found 
dramatically reduced mitochondrial flux (Figure 3.2), producing by altered organelle 
density, in mutant SNs. Indeed, the unexpected finding of reduced organelle density from 
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in vivo Parkin-deficient SNs (Figure 3.4) raises the idea that the reduced mitochondrial 
flux, the main defect in axonal transport that I found in mutant motor axons, is mostly 
caused by diminution in organelle quantity. This is the opposite of the result expected for 
Parkin deletion, if this pathway was driving clearance of senescent mitochondria from the 
axon. It is however consistent with our previous demonstration that manipulation of 
PINK1 also fails to effect mitochondrial arrest (Devireddy et al., 2015).  
Since the PINK1/Parkin pathway is proposed to be required for targeting 
damaged mitochondria (Narendra et al., 2008; Jin et al., 2010; Matsuda et al., 2010; 
Narendra et al., 2010; Lazarou et al., 2015), for local mitophagy (Ashrafi et al., 2014), 
and with promoting organelle fission (Clark et al., 2006; Deng et al., 2008; Poole et al., 
2010; Ziviani et al., 2010), the contrary result of axonal mitochondrial diminution further 
causes me to investigate the in vivo role of Parkin in neuronal mitochondrial turnover 
with considering organelle morphology. In neurons (Ashrafi et al., 2014) as well as non-
neuronal (Matsuda et al., 2010; Narendra et al., 2010) environments, mitochondria that 
undergo mitophagy mostly show an isolated and fragmented morphology. In this context, 
I asked whether those remaining mitochondria in mutant axons harbor any of 
morphologically and/or physiologically disrupted organelle state. Surprisingly, 
quantitative morphological analyses demonstrated that mutant animals preserved a 
normal state of axonal mitochondria despite their lower amount (Figure 3.8 and 3.9). This 
  	 
	  	  m: neither elongated organelles nor 
	 m were observed in the Parkin-deficient axons (Figure 3.10, B and C) as 
well as in their NMJs (Figure 3.11). Instead, I found a dramatic alteration of organelle 
morphology in mutant cell bodies (Figure 3.13) which consequently makes me to 
consider the compartmentalized in vivo role of Parkin in neurons. Thus, the collected 
results from in vivo larval motor neurons suggest that Parkin plays an important role in 
preserving the normal amount of mitochondria in axons and it seems to be critically 
associated with the modulation of organelle fission-fusion balance in cell bodies rather 





4.2 Compartmentalized Role of Parkin in Mature Neurons 
 
The morphological defects of mitochondria that I found specifically in park25 cell bodies 
raise the possibility of compartmentalized organelle QC regulated by Parkin in mature 
neurons. What could be restricting Parkin-dependent mitochondrial QC to cell bodies in 
vivo? Since mitochondria dynamically interact with other organelles, such as 
endoplasmic reticulum (ER), it is possible that the location of the ER network may 
contribute to the compartmentalized Parkin-dependent mitochondrial QC. In fact, ER 
tubules form membrane contact sites with a number of other organelles (Rowland and 
Voeltz, 2012; Rowland et al., 2014) and such contacts regulate diverse neuronal functions, 
including motor protein dependent organelle transport and neurite outgrowth (Raiborg et 
al., 2015). More important, it has been recently proposed that ER tubules also play a 
regulatory role in mitochondrial division by contacting mitochondria and causing their 
constriction prior to the recruitment of the mitochondrial fission protein Drp1 (Friedman 
et al., 2011). Because the neuronal ER network is mostly located adjacent to the outer 
layer of the nuclear envelope (Berridge, 1998; Verkhratsky and Petersen, 1998), it is 
plausible that mitochondrial morphology is particularly disrupted in cell body by Parkin 
perturbation. If the somatic compartment is the main location of neuronal mitochondrial 
turnover (Safiulina and Kaasik, 2013), the entry and exit of organelles between cell 
bodies and axons are critically important for regulating the neuronal mitochondrial life 
cycle. In this context, I propose another possibility: that mature neurons possess a 
physical barrier in-between the cell body and axon for restricting axonal entry of 
mitochondria to those of appropriate size, morphology and metabolic status. Thus, the 
disrupted fission-fusion balance caused by Parkin perturbation which produces inter-
    	
      	  
   	 
  
dysfunctional organelles into axon. This proposal is consistent with recent evidence that 
the pre-axonal exclusion zone in the hillock provides a cytoplasmic boundary for the 
entry of vesicles into axonal domain (Farias et al., 2015). 
 The hypothesis that new mitochondria are generated in the cell body to meet 
axonal requirements underlies the importance of organelle axonal transport, especially 
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anterograde movement. Indeed, it is notable that the same reduced-axonal-density 
phenotype that I observed has previously been reported in motor axons of Drosophila 
SNs with disrupted motor protein expression (Pilling et al., 2006). In that study, it was 
remarkable that only kinesin heavy chain mutants displayed reduced mitochondrial 
density in SNs, while mutations in dynein retained the normal compliment of axonal 
mitochondria. Furthermore, our previous report demonstrated that Parkin selectively 
restored the abnormal mitochondria of PINK1 mutants only in cell bodies, but not in 
axons (Devireddy et al., 2015). Taken together, these findings suggest a 
compartmentalized in vivo role of PINK1/Parkin in neuronal mitochondrial turnover and 
provide further evidence that the mitochondrial supply from the cell body is critically 
important for preserving organelle numbers and distribution in axons. 
 
 
4.3 Mitochondrial Quality Control In Vivo and In Vitro 
 
I did observe the morphological remodeling of mitochondria under stress conditions both 
in vivo and in vitro: 6 hours of starvation in vivo (Figure 3.15), as well as Ant A and H2O2 
treatment in vitro (Figure 3.18) both produced fragmented mitochondria even in the 
absence of Parkin. It is likely that mitochondrial fission can be regulated independently of 
Parkin and/or up-regulated by stress conditions that overwhelm normal physiological 
fusion. However, I was surprised to observe several dramatic distinctions in the 
mitochondrial life cycle between motor neurons in vivo and in vitro. First, I barely 
observed the AVs that co-localized with mitochondria throughout in vivo motor neurons, 
whereas Parkin-dependent mitophagy was obvious in the same neurons in vitro. Second, 
the axonal mitochondria which were preserved in the normal state in vivo were elongated 
and displayed diminished   in vitro in Parkin perturbation. Thus, unlike in vivo, my 
observations from in vitro neuronal culture system reasonably support the current 
proposed role of Parkin on mitochondrial QC, targeting senescent mitochondria and 
promoting mitochondrial fission.  
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 What could explain these differences? One possibility is that the mature neurons 
possess a thorough mitochondrial network constructed via an established physical filter 
in-between the cell body and axon, are which remains less-developed in vitro. In support 
of this idea, I noted that the most axonal mitochondria in vivo were morphologically 
nearly uniform and ~2 times shorter than axonal mitochondria in cultured neurons 
(Figure 3.8 and 3.19). In addition, axonal mitochondria in vitro often extended 
continuously from the cell body into the axon (Figure 3.18 A), a feature that is rarely if 
ever seen in vivo, suggesting that the filter between the cell body and axon is absent or 
more permissive in isolated cultured neurons. In this case, mitochondria that enter into 
axon would be more restricted and scrutinized in vivo than in vitro. Indeed, possible idea 
is in accord with the down-regulated mitophagy events that I observed in the in vivo 
larval nervous system. Perhaps the role of Parkin in mitochondrial fission-fusion balance 
is compartmentalized in the mature cell body and this may reduce the need for local 
mitophagy process in axons in vivo. In addition, I cannot exclude another possibility: that 
the mature neurons in vivo are functionally associated with surrounding cells and tissues 
that contribute to mitochondrial turnover. Recent evidence from mouse optic nerve head 
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mitochondrial turnover in the periphery, and could contribute to the lack of axonal 
mitophagy that I observed in vivo. 
 
 
In this study, I report the distinct and compartmentalized in vivo role of Parkin in 
mitochondrial QC. By comparing Drosophila motor neurons in vivo and in vitro, I find 
dramatic differences: despite their reduced amount, axonal mitochondria retain their 
normal state in Parkin-deficient mature neurons, whereas, in cultured axons the organelle 
morphology and inner membrane potential are critically affected by Parkin deletion. 
Instead, Parkin deficient animals display disrupted mitochondrial morphology 
specifically in the motor cell bodies. In addition, mitophagy is rarely observed in the 
mature Drosophila motor neurons, but it is regulated in a Parkin-dependent manner in the 
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in vitro cultured neurons. Unlike in vitro conditions, therefore, the in vivo role of Parkin 
does not appear obviously related to mitophagy, and is restricted to the cell body where it 
seems to modulate mitochondrial fission-fusion balance. Thus, these findings re-
emphasize the intricate interdependence of mitochondrial dynamics and axonal transport, 
and further suggest the importance of mitochondrial network between cell body and axon 
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